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ABSTRACT 
Objective: The goal of this research was to examine the clinical utility of the digital 
Clock in the Box (dCIB), a novel digitized cognitive screening test.  This was 
accomplished by (1) creating cutoff scores for the dCIB, (2) evaluating performance on 
the dCIB relative to established cognitive screening and standardized neuropsychological 
measures, and (3) determining the efficacy of the dCIB to screen for subtle cognitive 
deficits associated with poor vascular health.  Metabolic Syndrome (MetS; clinical 
syndrome of three or more cardiovascular risk factors) is a rising health epidemic 
associated with an increased risk for cerebrovascular disease and vascular dementia.  
Early detection of subtle deficits associated with MetS may assist in regulation of disease 
progression and prevention of future vascular dementia. 
Methods: A community-based sample of adults with no self-reported history of cognitive 
impairment was recruited for a cross-sectional study in which they completed a metabolic 
assessment, blood draw, and a brief neuropsychological battery consisting of the dCIB, 
the Mini-Mental State Exam (MMSE), and measures of executive function, memory, and 
attention. For part of the analysis, participants were separated into MetS (n=21) and non-







Results: Participants (N=63) were older (62.49 ± 9.16 years), educated (16.46 ± 2.76 
years), and diverse with 44.4% female (n=28) and 28.6% non-White (n=18). Receiver 
operating characteristic (ROC) analysis and Youden’s J statistic determined the optimal 
cutoff value for the dCIB as 5.5 (dCIB score ≤ 6 indicating suspected impairment; dCIB 
score ≤ 5 indicating probable impairment).  Performance on the dCIB (6.32 ± 2.32) was 
significantly correlated with the MMSE (28.19 ± 2.06); (Pearson’s r = 0.437, p = 0.000).  
The dCIB had better sensitivity (72.7%) but poorer specificity (65.4%) compared to the 
MMSE (sensitivity 45.5%; specificity 94.2%).  Using regression modeling, the dCIB 
significantly predicted performance on measures of executive function, memory, and 
attention.  In a sample stratified by vascular risk, the dCIB successfully differentiated 
MetS (5.33 ± 2.75) and non-MetS (6.81 ± 1.93) groups, with lower dCIB scores in the 
MetS group relative to the non-MetS group (F = 8.975, p = 0.004).   
Conclusion: The dCIB is a novel digitized clock drawing task designed to screen for 
cognitive impairment.  Clinical utility for the dCIB was established by determining its 
test validity and demonstrating its sensitivity to detect subtle cognitive deficits in a 
sample with vascular risk.  Because the dCIB is simple to administer and brief to 
complete, it may be an ideal option for routine cognitive screening in primary care 
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CHAPTER ONE – INTRODUCTION 
Significance 
Dementia, which describes a decline in cognitive functioning that eventually leads 
to a loss of independent function, is a common and feared neurological syndrome among 
the geriatric population (Gale et al., 2018).  An estimated 50 million individuals are 
currently living with dementia worldwide, with future projections of 152 million by 2050 
(World Health Organization, 2020).  More than 5 million U.S. adults over the age of 65 
have dementia, and this number is expected to triple by 2050 (Alzheimer’s Association, 
2020).  Dementia is a major source of disability and reflects one of the most expensive 
challenges facing healthcare.  The total lifetime cost of care for someone with dementia is 
estimated at $357,297 (Alzheimer’s Association, 2020), with worldwide annual costs 
estimated at $818 billion (World Health Organization, 2020).  In addition to the financial 
cost, there is tremendous burden on dementia caregivers, the majority of whom are 
family members of the patient, with evidence of an association between caregiver stress 
and elevated levels of depression and anxiety (Cheng, 2017). 
Dementia is not itself a disease, but the clinical presentation of an underlying 
disease (Centers for Disease Control, 2019; Gale et al., 2018).  The two most common 
etiologies of dementia are Alzheimer’s Disease (AD) and vascular disease (VD) (Centers 
for Disease Control, 2019), leading to AD dementia and vascular dementia, respectively.  
AD is a progressive neurodegenerative disease typically characterized by initial problems 





the disease spreads across the brain from the medial temporal lobes to the association 
cortices of the frontal, temporal, and parietal lobes, AD typically changes from a memory 
disorder to a global brain disorder and eventually leads to deficits in a number of other 
cognitive domains including language, abstract reasoning, executive function, and 
visuospatial ability (Alzheimer’s Association, 2020; Amirrad et al., 2017; Bondi et al., 
2017). Vascular dementia is characterized by significant cognitive decline in a fluctuating 
or stepwise pattern which reflects the course of neuroanatomical changes that result from 
a variety of vascular events (e.g., small vessel disease, stroke) that may be caused by 
uncontrolled or poorly controlled metabolic risk factors (e.g., hypertension, obesity) 
(Dichgans & Leys, 2017; Smith, 2017).  These neuroanatomical changes have been 
shown to impact a series of parallel pathways that interconnect various regions of the 
frontal lobe to subcortical structures, leading to deficits in cognitive domains dependent 
upon the integrity of these frontal-subcortical circuits including frontally mediated 
executive functions and attention (Sudo et al., 2017; Pugh & Lipsitz, 2002).  Diagnosis 
for dementia is met if there is substantial impairment in one or more cognitive domains 
and the impairment is sufficient enough to interfere with independence in everyday 
activities (American Psychiatric Association, 2013).  If the etiology is suspected AD, 
cognitive decline usually begins in the domain of memory and eventually progresses to 
affect all cognitive domains (e.g., executive function, language, visuospatial ability); if 
the etiology is vascular, cognitive decline is usually in the domains of executive function 





Psychiatric Association, 2013).  It is well documented that executive functioning, in 
particular, is the strongest cognitive predictor of everyday “real world” functioning (i.e., 
planning, decision making) (Mansbach & Mace, 2019; McDougall et al., 2019; Farias et 
al., 2009), and therefore executive dysfunction may negatively impact functional 
independence.  Cognitive deterioration associated with progressive dementias eventually 
leads to a loss of functional independence including difficulties performing basic 
activities of daily living (ADL; e.g., bathing, dressing) and complex instrumental 
activities of daily living (IADL; e.g., shopping, managing finances) (Slachevsky et al., 
2019). 
Timely diagnosis of dementia may have a significant impact on the care, 
treatment, and quality of life for patients.  An early diagnosis may provide options and 
opportunities for patients and their families including planning for the future (e.g., 
finances, power of attorney, preparation of a last will and testament), taking advantage of 
patient support and other appropriate services, and accessing interventions and therapies 
(e.g., clinical trials, medication) (Dhedhi et al., 2014; Morley et al., 2015; Phillips et al., 
2011; Phillips et al., 2012).  However, current estimates indicate almost half of 
individuals living with dementia are undiagnosed or diagnosed later into the disease 
progression (Jammeh et al., 2018; Connolly et al., 2011).  Recent estimates of cognitive 
impairment among patients are as high as 30%, of which 30% to 75% go unrecognized 
by attending physicians (Palsetia et al., 2018).  There are a number of healthcare barriers 





cognitive assessment and time constraints related to the short duration of primary care 
visits (Sabbagh et al., 2020; Aminzadeh et al., 2012; Bradford et al., 2009).  Training 
programs for primary care physicians provide limited exposure to cognitive assessment 
and, as a result, many physicians report feeling poorly equipped, inexperienced, or 
uncomfortable monitoring cognitive functioning (Lee et al., 2018).  A recent survey 
found that 22% of primary care physicians had no residency training in dementia 
diagnosis and/or care – and among the 78% who had training, 65% reported that the 
training was “very little” (Alzheimer’s Association, 2020).  Furthermore, primary care 
visits are often less than 20 minutes (Linzer et al., 2015) which limits the time and depth 
of cognitive assessment available to patients (Bradford et al., 2009; Chen et al., 2009).  
The short duration of the average clinic visit reflects a key obstacle to the practice of 
cognitive evaluation in primary care and highlights the need for brief tests in this setting.  
Despite these barriers, it is important for physicians to monitor cognitive status in their 
patients.  Some physicians are uncertain that a dementia diagnosis, particularly in the 
early stages, provides a clear benefit to the patient given that there is currently no 
effective treatment for dementia (Sabbagh et al., 2020; Bradford et al., 2009).  However, 
encouraging results from clinical trials and other recent advances in dementia research 
offer hope that one or more disease-modifying treatments are on the horizon (Sibley et 
al., 2019; Liu et al., 2017).  Given the potential for a therapy, there is need for routine 
cognitive screening to ensure that patients in early stages of dementia are identified in a 





treatable or reversible etiologies of dementia (e.g., metabolic abnormalities; vitamin 
deficiencies) (Sibley et al., 2019) as well as identifying cognitive changes in at-risk 
populations (Roebuck-Spencer et al., 2017) for which there is evidence that primary care 
screening contributes to higher rates of detection compared to informal observation alone 
(Cordell et al., 2013).   
Detecting dementia may be challenging due to the nature of the syndrome itself 
and the complexity of dementia diagnosis.  Not only are there many etiologies of 
dementia (e.g., Alzheimer’s Disease, vascular disease), clinical symptoms are often non-
specific and may overlap with other medical conditions such as mood disorders (i.e., 
depression) (Rubin, 2018).  Furthermore, preclinical or early stages of dementia present 
with mild symptoms at onset, making it difficult to attribute symptoms to dementia.  
Later stages of dementia may go undetected due to the incorrect belief that significant 
cognitive impairment is a normal part of aging or the bias that diagnostics are 
unnecessary for conditions without treatment (Phillips et al., 2011; Bradford et al., 2009).  
Differentiating symptoms of dementia from cognitive changes that reflect normal aging 
(e.g., declines in speed of information processing, problems remembering names) often 
serves as a challenge in healthcare settings (Phillips et al., 2011), thereby reflecting the 
need for reliable tools to aid in dementia screening. Neuropsychological assessment is a 
performance-based method of measuring cognitive functioning through the 
administration of standardized, norm-based psychological tests.  Using a comprehensive 





functioning, memory, attention, language, visuospatial abilities) and overall performance 
can indicate severity of impairment and aid in diagnosis and/or treatment planning 
(Roebuck-Spencer et al., 2017). As the gold standard for cognitive evaluation, 
neuropsychological assessment may be helpful in identifying subtle cognitive deficits 
associated with early stages of dementia.  However, testing batteries are often lengthy 
(i.e., 2 to 5 hours to administer) and require specialized training to administer (i.e., by a 
licensed clinical neuropsychologist) (Muller et al., 2017), making their use unfeasible in 
primary care settings (Sudo et al., 2017).  Instead, “brief and widely accessible tests 
would be more suitable for clinical use than extensive sophisticated neuropsychological 
batteries” (Sudo et al., 2017, p. 372).  Cognitive screening tests are usually brief and 
narrow in scope and can be used as part of a routine clinical visit to identify the presence 
of cognitive impairment (Roebuck-Spencer et al., 2017).  Although cognitive screeners 
are not in and of themselves diagnostic, they may indicate the likelihood of cognitive 
impairment and help identify patients who require more extensive, comprehensive, and 
diagnostic neuropsychological assessment (Roebuck-Spencer et al., 2017).  Key 
differences between cognitive screening tests and comprehensive neuropsychological 







Summary of Key Differences between Cognitive Screening Tests and Comprehensive 
Neuropsychological Batteries 
 Cognitive Screening Tests Comprehensive 
Neuropsychological Batteries  
 
Potential Uses • Early identification of 
individuals at potential risk 
for condition or disorder 
 
• May indicate need for further 
evaluation or intervention 
 
• May be used to monitor 
progression of symptoms or 
response to intervention 
 
• Does not provide definitive 
diagnosis 
 
• Determination of presence and 
magnitude of impairment  
• Determination of diagnoses 
• Determination of functional 
status, abilities, and capacities 
• Assistance with medical 
treatment planning 
Administration • Generally brief (<30 min) 
 
• May be administered as part 
of routine clinical visit 
 
• Requires minimal training for 
administrator or can be self-
administered 
• Varies but typically several 
hours 
 
• Typically occurs as a separate 
encounter or appointment 
 
• Requires specialized training 
in administration and 
interpretation 
 
Domains Assessed • Narrow in scope • Multidimensional 
 
• Provides information about 




Note. Reprinted with permission from “Cognitive Screening Tests versus Comprehensive 
Neuropsychological Test Batteries: A National Academy of Neuropsychology Education 
Paper” by T. M. Roebuck-Spencer, T. Glen, A. E. Puente, R. L. Denney, R. M. Ruff, G. 
Hostetter, and K. J. Bianchini, 2017, Archives of Clinical Neuropsychology, 32(4), p. 495 






As the elderly population continues to grow, early detection of cognitive changes 
and of possible underlying dementia becomes increasingly important (Segal-Gidan, 
2013).  Cognitive screening tools are an attractive option for detecting compromised 
cognitive functioning because they are rapid, non-invasive, and inexpensive.  It is 
important to note that screeners are not intended to be stand-alone tests, nor are they 
meant to take the place of a more comprehensive neuropsychological evaluation. Rather, 
they are intended to provide healthcare providers with quick feedback regarding 
cognitive status that can help inform medical recommendations.  When used properly, 
cognitive screeners are designed to flag cognitive changes so that patients may be 
referred to a specialist (e.g., clinical neuropsychologist, neurologist, occupational 
therapist) who can provide further evaluation and assist in cognitive assessment and 
symptom management.  An ideal cognitive screening tool has high sensitivity (i.e., true 
positive rate; individuals with impairment correctly classified as cognitively impaired) as 
well as high specificity (i.e., true negative rate; individuals who are unimpaired correctly 
identified as not having cognitive problems) (Segal-Gidan, 2013).  Values for sensitivity 
and specificity range between 0% and 100% and “well-designed tests usually try to 
maximize both criteria, allowing trade-offs to reflect the consequences of making an 
incorrect decision” (Hebben & Milberg, 2009, p. 45). 
A great number of cognitive screening instruments have been developed, with a 





including both paper-and-pencil and computerized tasks (de Roeck et al., 2019).  Among 
the screeners frequently used in clinical practice today are the Mini-Mental State Exam 
(MMSE-2; Folstein et al., 2010), the Montreal Cognitive Assessment (MoCA; 
Nasreddine et al., 2005), and the Saint Louis University Mental Status (SLUMS; Tariq et 
al., 2006).  The MMSE is an 11-item test that assesses five domains: registration, 
orientation, attention and calculation, verbal recall, and language [possible score range of 
0-30; cutoff score of ≤25 for suspected impairment].  The MMSE is the most commonly 
used cognitive screener for dementia (de Roeck et al., 2019; Tsoi et al., 2015) and has 
become the reference against which other measures are judged.  Designed to detect 
milder forms of cognitive impairment, the MoCA is the second most commonly used 
screener and includes items assessing visuospatial ability, executive function, naming, 
memory, attention, language, abstraction, delayed recall, and orientation [possible score 
range of 0-30; cutoff scores of ≤25 for suspected MCI and ≤ 20 for suspected dementia].  
The MoCA has been administered to a wide range of populations and disorders including 
mild cognitive impairment [MCI] (Abd Razak et al., 2019; Ciesielska et al., 2016), 
Alzheimer’s Disease [AD] (de Roeck et al., 2019; Pinto et al., 2019; Davis et al., 2015), 
Parkinson’s Disease [PD] (Dalrymple-Alford et al., 2010; Hoops et al., 2009), vascular 
dementia (Ghafar et al., 2019; Freitas et al., 2012), traumatic brain injury [TBI] (Frenette 
et al., 2019; de Guise et al., 2014), Huntington’s Disease [HD] (Bezdicek et al., 2013; 
Gluhm et al., 2013; Videnovic et al., 2010), and multiple sclerosis [MS] (Freitas et al., 





supporting its use (de Roeck et al., 2019; Siqueira et al., 2019).  However, despite its one-
page format, the MoCA requires the longest administration time among the three tests 
(Slavych, 2019) which may make it difficult to use in a busy clinic setting.  The SLUMS 
is similar to the MMSE in format (i.e., 11 items) but it offers enhanced tasks of attention 
and calculation, immediate and delayed recall, and figure recognition, along with novel 
tasks of animal naming, digit span, clock drawing, and story/narrative memory [possible 
score range of 0-30; score of 21 to 26 for suspected MCI and ≤ 20 for suspected 
dementia].  The most notable disadvantage of the SLUMS is its lack of use with different 
clinical populations and the dearth of research regarding its psychometric properties 
(Slavych, 2019).  Because the MMSE demands little time to administer and has been 
used with various patient populations (e.g., MCI/dementia, stroke, Parkinson’s Disease, 
depression) with substantial literature regarding its psychometric properties (Carnero-
Pardo, 2014), it is often the preferred cognitive screener over the MoCA and SLUMS. 
The MMSE is user-friendly and its ease and brevity are among the reasons for its 
popularity with healthcare providers (Palsetia et al., 2018).  The MMSE is utilized in 
most medical institutions making its administration and interpretation universally 
understood, which has facilitated its placement as the benchmark cognitive screener 
(Carnero-Pardo, 2014).  Furthermore, there are vast amounts of available data using the 
MMSE, which makes it easy to find standards for comparison in a variety of different 
settings (Carnero-Pardo, 2014).  However, the MMSE has a number of notable 





minutes, making this test relatively time consuming among individuals with serious 
cognitive impairment (Rakusa et al., 2018).  Among individuals with mild cognitive 
impairment (MCI), the MMSE has been criticized for its insensitivity in detecting early 
cognitive changes, and thereby its limited ability to differentiate between MCI and 
healthy controls (de Roeck et al., 2019; Mitchell, 2009).  This finding initiated the 
creation of more sensitive screeners, such as the MoCA and SLUMS, to detect subtle 
deficits that may otherwise go undetected by the MMSE (Nasreddine et al., 2005; Tariq 
et al., 2006).  A meta-analysis determined MMSE test sensitivity to range from 71% to 
85% and MMSE test specificity to range from 81% to 96% when screening for dementia 
and mild cognitive impairment (MCI) (Mitchell, 2009).  In primary care, sensitivity 
values as low as 64% have been reported for the MMSE (Larner, 2018).  Furthermore, 
false positives on the MMSE have been linked to older age, limited education, foreign 
culture, depression, and sensory impairment (Palsetia et al., 2018).  Widespread use of 
the MMSE may result in practice effects or patients learning appropriate responses 
(Palsetia et al., 2018).  Perhaps the greatest limitation that has been identified in the 
literature is that the MMSE excludes an assessment of executive functioning, which may 
make this screener unsuitable for identifying executive deficits (Palsetia et al., 2018; 
Rakusa et al., 2018).  This is supported by research showing that the MMSE is less 
sensitive to frontal and subcortical changes (i.e., regions implicated in vascular disease 





MMSE may not meet the current needs for dementia screening, and perhaps another test 
would be more suitable.   
Neuropsychological Approach to Clock Drawing 
In recent years, clock drawing has become a popular cognitive screening tool 
because of its brief and simple administration, acceptability among patients, low cost, 
good psychometric properties, sensitivity to subtle cognitive impairment, and evidence of 
significant correlations with other established and validated cognitive tests (i.e., MMSE) 
(Hazan et al., 2018; Ismail et al., 2010; Nyborn et al., 2013; Rabin et al., 2005; Shulman, 
2000; Shulman et al., 2006).  Clock drawing taps into an array of cognitive abilities that 
span across a number of domains – verbal comprehension (i.e., comprehending 
instructions); verbal working memory (i.e., recalling and holding instructions in mind); 
visual memory (i.e., retrieving a mental representation of a clock); executive function 
(i.e., developing an organized multi-step plan of action; detecting and correcting errors); 
visuospatial ability (i.e., mentally constructing the clock; judging line length and 
orientation for the hour and minute hands); symbolic knowledge (i.e., demonstrating 
intact symbolic representation of the twelve numbers and hour and minute hands set to 
represent time); sustained attention (i.e., concentrating to complete the task); and fine 
motor skills (i.e., constructing an accurate and organized layout of a clock) (Young, 
2018; Freedman, 1994; Amodeo et al., 2015) – and errors in one or many of these areas 





 Support for the use of clock drawing as a cognitive screener comes from studies 
demonstrating its strong psychometric properties (Shulman, 2000) including high levels 
of diagnostic accuracy (Carnero-Pardo et al., 2019; Duro et al., 2019; Nair et al., 2010; 
Park et al., 2018; Vyhnalek et al., 2017), inter-rater reliability (Fuzikawa et al., 2003; 
Nair et al., 2010), and test-retest reliability (Hubbard et al., 2008; Mendez et al., 1992; 
Strauss et al., 2006).  There are a number of existing versions of clock drawing, with 
three major differences between the versions: the clock circle (i.e., whether the circle 
should be pre-drawn or drawn by the examinee); the time the clock is set (i.e., “ten after 
eleven”); and the scoring system (see Palsetia et al., 2018 for a review) (Rakusa et al., 
2018).  Depending on the version used, test sensitivity ranges from 67% to 98% and test 
specificity from 69% to 95% when screening for possible dementia (Smedslund et al., 
2015). Recent data suggests sensitivity as high as 84% to 90% and specificity 76% to 
78% in diagnosing patients with Alzheimer’s Disease (Duro et al., 2019).  Furthermore, 
clock drawing has been shown to have significant correlations with other established 
cognitive tests including verbal fluency, verbal learning and recall, Block Design, Digit 
Symbol, Trail Making Test, Rey-Osterrith Complex Figure, Mini-Mental State 
Examination, Hooper Visual Organization Test, and Raven’s Colored Progressive 
Matrices (Grande et al., 2013; Shulman, 2000). 
Clock drawing has a rich history in neuropsychological testing (Frankenburg, 
2019; Hazan et al., 2018).  The first documented clinical case of clock drawing dates 





of his medical evaluations of individuals with difficulties speaking, reading, writing, and 
understanding language (i.e., aphasia) (Frankenburg, 2019; Hazan et al., 2018).  Head 
asked patients to set a clock based on written commands and verbal commands, to state 
the time, and to write down the time (Head, 1926). In his book Aphasia and Kindred 
Disorders of Speech, Head (1926) reviewed findings from several clinical cases, making 
note of interesting patterns of behavior including slow completion time and 
inconsistencies in verbal and written time telling. 
In addition to capturing language deficits in aphasia, clock drawing was also used 
to assess constructional apraxia in World War II soldiers who suffered head injuries to 
the occipital and parietal lobes (Spenciere et al., 2017).  Trauma to these brain regions 
was associated with the inability to spontaneously draw objects and copy figures (i.e., 
constructional apraxia), which could be successfully evaluated by asking injured soldiers 
to draw a clock (Spenciere et al., 2017).   
 As the field of neuropsychology burgeoned in the 1970s, clock drawing became 
more prevalent in the literature.  In a seminal book entitled The Assessment of Aphasia 
and Related Disorders, Edith Kaplan and Harold Goodglass (1972) outlined tests of 
clock drawing, clock copying, and clock setting.  In the clock drawing condition, patients 
were asked to “draw the face of a clock showing the numbers and the two hands, set to 
ten after eleven” (Goodglass et al., 1983).  In the copy condition, patients were asked to 
copy an already drawn clock. Scoring for clock drawing and clock copying was based on 





accuracy of numbers (Goodglass et al., 1983).  In the clock setting condition, patients 
were presented with four clock faces and asked to set the times to 1:00, 3:00, 7:30, and 
9:15 (Goodglass et al., 1983).  Scoring for clock setting was out of a possible three points 
on appropriate length of hour and minute hands, correct hour hand placement, and correct 
minute hand placement (Goodglass et al., 1983).  Although all three tests rely on 
overlapping cognitive domains (i.e., language, memory, executive function), each test 
highlights specific cognitive processes. Clock drawing measures comprehension of verbal 
instructions (i.e., language), recall of the semantic representation of a clock (i.e., 
memory), recall of the instructions for time setting (i.e., working memory), and planning 
clock size and orientation (i.e., executive function) (Freedman et al., 1994).  Tests of 
clock drawing are sensitive to temporal lobe dysfunction exhibited by language deficits 
(in the language-dominant, usually left, hemisphere) and/or memory deficits (both 
hemispheres) as well as frontal lobe dysfunction resulting in executive deficits (Freedman 
et al., 1994).  Clock copying is an assessment of perceptual functioning, making it a 
sensitive test for parietal lobe dysfunction (Freedman et al., 1994). Clock setting has been 
linked to bilateral hemi-attentional processing and executive functions (Freedman et al., 
1994).  Kaplan’s choice of “ten after eleven” for clock drawing required patients to draw 
the minute hand and the hour hand on each side of the clock (i.e., bilateral hemi-
attentional processing) and to process information semantically, instead of perceptually, 
thereby requiring patients to re-code “ten” in order to set the minute hand to the correct 





especially interested in the types of errors patients made on the clock drawing test, as 
error type could help inform lesion localization (Grande et al., 2013).  The types of errors 
common in patients with frontal lobe dysfunction (e.g., vascular dementia) include 
planning errors (e.g., misjudging size of the clock, improper spacing of numbers) and 
stimulus-bound errors (e.g., inability to re-code “ten” to the number two), which reflect 
underlying deficits in executive function and inhibition (Lee et al., 2009; Salmon & 
Filoteo, 2007).  Errors made by patients with temporal lobe dysfunction (e.g., 
Alzheimer’s dementia) may be conceptual errors (e.g., misrepresenting the clock by 
drawing a face, writing the time in the clock face) which reflect deficits in accessing 
knowledge of the features and meaning of a clock (i.e., loss of semantic memory, 
impairment in semantic knowledge) (Lee et al., 2009; Salmon & Filoteo, 2007).  Kaplan 
and Goodglass administered their set of clock tests to aphasic patients and used that data 
to create the first database on clock drawing (Goodglass et al., 1983). 
 Scoring guidelines were created by Shulman and colleagues (1986) to flag 
cognitive impairment in a sample of 75 older individuals with and without neurocognitive 
disorders.  The results from this study identified significant correlations between clock 
drawing and existing short measures of global cognition (e.g., Mini-Mental State Exam 
[MMSE; Folstein et al., 1975]) (Shulman et al., 1986).  Based on these findings, Shulman 
was among the first to suggest the use of clock drawing as a clinical screener for 
cognitive impairment in the elderly—a suggestion Shulman himself followed when 





(Shulman et al., 1986).  Shulman’s work reflected a shift away from using clock drawing 
as a measure of domain-specific impairment and instead, an introduction of clock 
drawing as a screening instrument. 
Over the past decade, there has been an increasing trend towards the utilization 
and incorporation of digital technologies to modernize current approaches to 
neuropsychological assessment, including clock drawing (Parsons & Duffield, 2019).  
This trend reflects the increased accessibility of technological devices in the digital era 
(i.e., desktop computers, laptop computers, smartphones, tablets) and how data from 
these devices may provide behavioral measurement with a level of precision and 
standardization that is difficult or otherwise impossible to achieve with traditional paper-
and-pencil neuropsychological assessment (Germine et al., 2019).  The potential benefits 
of digitized testing over paper-and-pencil testing are numerous: “the capacity to test a 
large number of individuals quickly; ready availability of assessment services without 
advance notice; the ability to measure performance on time-sensitive tasks, such as 
reaction time, more precisely; potentially reduced assessment times through the use of 
adaptive testing protocols; reduced costs related to test administration and scoring; ease 
of administering measures in different languages; automated data exporting for research 
purposes; increased accessibility to patients in areas or settings in which professional 
neuropsychological services are scarce; and the ability to integrate and automate 
interpretive algorithms such as decision rules for determining impairment or statistically 





One cognitive test that has incorporated digital technologies is clock drawing. For 
example, The Digital Clock Drawing Test [dCDT] (Davis et al., 2010; Penney, Davis, et 
al., 2010; Penney, Libon, et al., 2010) utilizes digital pen technology with software 
developed by Lahey Clinic and the Massachusetts Institute of Technology (MIT).  The 
instructions used to administer the dCDT are consistent with traditional clock drawing 
administration (i.e., draw the face of a clock, put in all the numbers, set the hands for 10 
after 11) (Davis et al., 2014).  The off-the-shelf digital pen (from Anoto Inc.) can be used 
on regular paper and functions like an ordinary ballpoint while simultaneously measuring 
its position on the paper every 12ms with an accuracy of ± 0.002 (Davis et al., 2014).  
Data collected with the dCDT is time-stamped, allowing the pen to digitally capture the 
final drawing (i.e., clock) as well as the behaviors that produced it (e.g., pauses, 
hesitations, drawing time, thinking time [time spent simply holding the pen and 
presumably thinking]) (Davis et al., 2014).  Furthermore, time-stamped data also means 
the program can play back a recording of how the clock was drawn (e.g., stroke 
sequence, pen speed, perseverations, errors) which allows for later review (Davis et al., 
2014).  This level of sensitivity to graphomotor characteristics and decision-making 
latencies may provide more precise and accurate data than what can otherwise be 
gathered through traditional assessment (Diaz-Orueta et al., 2020; Germine et al., 2019). 
The Lahey Clinic/ MIT software classifies each pen stroke as a clock feature (i.e., clock 
face, clock numbers, clock hands) with up to 84% accuracy in healthy controls (Penney, 





number of strokes associated with individual clock features; the dimensions and 
orientation of the clock face, clock numbers, and clock hands; the time elapsed during 
and between drawing individual clock features; and deviations of clock features from 
ideal placement (Davis et al., 2014; Binaco et al., 2020). 
The dCDT has been used with both healthy controls and patient populations to 
explore individual differences in graphomotor organization and decision-making.  
Among patients with multiple sclerosis (MS), Libon et al. (2014) demonstrated slowed 
latencies and longer completion time on the dCDT, which supports the presence of 
bradyphrenia (i.e., reduced processing speed) often observed in this population.  In a 
sample of patients diagnosed with major depression, Cohen et al. (2014) found that 
younger patients spent a smaller proportion of time actually drawing (i.e., “ink” time; 
total time the pen is in contact with the paper) relative to not drawing (i.e., “think” time; 
total time the pen is not in contact with the paper) compared to older patients.  Despite 
similar overall performance on the dCDT, nuanced differences in “ink” time and “think” 
time differentiated aspects of psychomotor slowing between older and younger depressed 
groups (Cohen et al., 2014).  Lamar et al. (2016) found that individuals who use anchor 
numbers on clock drawing (i.e., 3, 6, 9, 12) required fewer strokes to complete the dCDT 
and demonstrated overall better performance on tasks of executive function and 
learning/memory/recognition compared to individuals who do not use anchor numbers.  
In a large sample of older adults, Piers et al. (2017) demonstrated an effect of age on total 





demonstrated dCDT performance differences between older adults with and without mild 
cognitive impairment (MCI), such that slower total completion time, larger clock faces, 
and longer “think” time were observed in the group with MCI compared to the group 
without MCI.   
When screening for cognitive impairment, the need for quick feedback regarding 
cognitive status has motivated the use of machine learning (Bratic et al., 2018; Yim et al., 
2020).  Machine learning is an algorithm that can learn patterns from complex 
neuropsychological data in order to classify patients using either a binary classification 
(i.e., demented; not demented) or ternary classification (i.e., healthy; cognitively 
impaired; demented) (Bratic et al., 2018).  Using a classification system provides an 
immediate and automated diagnosis, which optimizes time and efficiency in healthcare 
settings (i.e., primary care) as manual scoring of data is not only time consuming, but 
scores may be subject to error (i.e., not objective or consistent) by busy clinic staff 
(Bratic et al., 2018).  Furthermore, an automated diagnosis makes the use of cognitive 
screeners more feasible in healthcare settings as specialized clinicians (i.e., licensed 
clinical neuropsychologists) are not required for immediate score interpretation (Bratic et 
al., 2018). 
Machine learning algorithms have been proposed to help establish the relationship 
between features of dCDT performance and level of cognitive decline (Binaco et al., 
2018; Davis et al., 2014; Souillard-Mandar et al., 2016).  Using machine learning, Davis 





from patients with Alzheimer’s Disease (AD) and other dementias.  Souillard-Mandar et 
al. (2016) reported classification rates on dCDT data from healthy controls, patients with 
mild cognitive impairment (MCI), and patients with several other dementias using a 
variety of machine learning methods.  Lastly, Binaco et al. (2018) demonstrated the 
ability of a machine learning algorithm with hundreds of features from dCDT drawings to 
classify mild cognitive impairment (MCI) subtypes and AD with 70-80% accuracy.  
Altogether, these studies suggest that machine learning may help improve diagnostics of 
cognitive impairment on tasks of clock drawing.  
The use of a digital pen is not the only technological advancement that has been 
applied to clock drawing.  In the last year, researchers have begun to develop clock 
drawing tests that utilize a digital interface (i.e., computer, tablet), including a digital 
clock drawing test administered on a Windows Surface Pro 4 tablet with a handheld 
stylus pen (Muller et al., 2019; Zhao et al., 2019).  Similar to traditional clock drawing 
instructions, participants are asked to draw the face of a clock with all the numbers and to 
set the hands to 10 after 11 (Muller et al., 2019; Zhao et al., 2019).  Zhao and colleagues 
administered this test to a sample of older adults with cerebral small vessel disease and 
observed an effect of disease severity on test performance, such that patients with severe 
small vessel disease performed worse on digitized clock drawing compared to patients 
with little/no small vessel disease (Zhao et al., 2019).  Muller and colleagues have also 
used this test to demonstrate the diagnostic value of digitized clock drawing in 





In one study, Muller et al. (2017) found that the time to transition the stylus from one 
stroke to the next (i.e., time-in-air; similar to “think” time) on the digitized test yielded 
higher diagnostic accuracy when discriminating between MCI patients and healthy 
controls than the use of the traditional paper-and-pencil test.  In a later study, Muller et al. 
(2019) demonstrated how digitized clock drawing holds comparable diagnostic values to 
other screening tests (i.e., CERAD) when discriminating between patients with MCI 
and/or AD and healthy controls.  Although digitized clock drawing is relatively new in 
the literature, these early findings are encouraging and provide preliminary support for 
the use of digitized clock drawing as a screening instrument. 
Introduction of the Clock in the Box 
One modified version of the classic clock drawing test is the Clock in the Box 
(CIB) (Grande et al., 2005; Grande et al., 2011a).  This modification was reportedly 
included to increase working memory demands with the goal of increasing sensitivity of 
the task (L. J. Grande, personal communication, October 25, 2019).  Participants are 
provided written instructions before completing the task, requiring them to hold the 
instructions in mind (i.e., WM; working memory) with specific directions to draw in a 
predetermined location on the response sheet (i.e., P/O; planning/organization).  The 
inclusion of these executive elements was designed to make the CIB a more 
comprehensive screener for cognitive impairment compared to alternative screeners on 





During administration of the CIB, participants are given a sheet of paper with a 
set of four instructions: (1) In the blue box on the next page, (2) Draw a picture of a 
clock, (3) Put in all the numbers, and (4) Set the hands to ten after eleven. The 
instructions are taken away and participants are free to draw on the response sheet that 
shows four colored boxes (yellow, red, green, blue) each in a quadrant.  A sample CIB is 
illustrated in Appendix A. 
Performance on the CIB is based on specific scoring criteria (see Appendix B).  
Each CIB is scored using an 8 point total scale (1 point each, range of 0 to 8, with lower 
scores indicating poorer performance) consisting of a 4 point Working Memory (WM) 
subscale and a 4 point Planning/Organization (P/O) subscale.  Overall scoring criteria 
include location in the blue box, resemblance to a clock, number inclusion, number order, 
number spacing, correct time, appropriate size, and hand length and origin.  The working 
memory component scores details specific to the set of written instructions, while the 
planning/organization component scores organizational and abstract features of the clock. 
To date, the CIB has been used for cognitive screening in a handful of 
populations.  In a sample of older hospitalized veterans, poorer performance on the CIB 
predicted discharge to a location other than home following hospitalization (e.g., 
subacute rehabilitation facilities, nursing facilities) (Jackson et al., 2016).  Among cardiac 
surgery patients, better pre-operative cognitive status, as measured by the CIB, was 
significantly associated with discharge to home following surgery (Harrington et al., 





prognosis in a sample of older patients with hematologic cancers (Hshieh et al., 2018).  
Performance on the CIB has been shown to be predictive of glycemic control among 
elderly Type 1 diabetic patients (Munshi et al., 2006).  CIB performance has also been 
shown to predict performance on other standardized measures of executive function in an 
elderly community sample (Chester et al., 2011), as well as older patients with 
cardiovascular risk (Grande et al., 2011b). 
The CIB was recently converted from a paper-and-pencil format to a digitized 
format.  This modification was made to assist in making the CIB more attractive to 
healthcare providers and to provide a standardized administration. The digital Clock in 
the Box [dCIB] is a novel digitized clock drawing task administered on an iPad tablet 
with a stylus pen. 
The dCIB shares many features with existing digitized clock drawing tests (i.e., 
dCDT and Windows Surface Pro 4, as discussed above).  All three tests require 
examinees to draw the clock face (i.e., no pre-drawn circle), to set the clock to the same 
time (i.e., ten after eleven), and to use a handheld pen to complete the drawing (i.e., 
digital pen for the dCDT; stylus pen for the dCIB and Windows Surface Pro 4).  In 
addition to similar administration, these tests all record drawing performance which can 
be used to evaluate important qualitative details of how the clock was drawn (i.e., time to 
completion, order of clock details, self-corrections) and inform behavioral and cognitive 





The dCIB offers a number of advantages over existing digitized clock drawing 
tests.  One advantage is its inclusion of executive elements, which we postulate makes the 
dCIB more sensitive to executive dysfunction and thereby furthers its utility beyond other 
clock drawing tests.  Another advantage is that the dCIB program is designed to score 
performance and compare it to normative data in real time.  This feature offers healthcare 
providers immediate feedback (i.e., score indicating performance outside normal limits) 
that can be used to inform on-the-spot medical recommendations.  This is in contrast to 
the dCDT which utilizes a sophisticated digital pen to record clock drawings that are later 
downloaded and scored by Lahey Clinic/MIT software, as well as data from the clock 
drawing test administered on the Windows Surface Pro 4 tablet which is scored by hand.  
Although administration and collection of clock drawings on the Windows Surface Pro 4 
is similar to that of the iPad, its functionality is limited as data cannot be immediately 
scored and interpreted. 
The goal of this research is to examine the clinical utility of the dCIB.  Evidence 
that the dCIB can detect early changes to cognition among those who have not yet been 
identified as cognitively impaired (i.e., have not been referred for a neuropsychological 
assessment or evaluation of cognition) would help establish its utility as a successful 
cognitive screener.  Individuals with vascular risk, who may exhibit subtle cognitive 
deficits that can go unnoticed by the patient and his or her friends and family (Ng et al., 







Because subtle cognitive impairment precedes dementia (Farias et al., 2017), 
early detection of these changes may help identify those at greater risk for developing 
dementia in the future.  Poor vascular health, marked by the presence of three or more 
cardiovascular risk factors, has been identified as a major cause of cognitive impairment 
and dementia in the growing aging population (Anand et al., 2020; Atti et al., 2019; Lai et 
al., 2020; Lee et al., 2020; Saklayen, 2018; Song et al., 2020; Zheng et al., 2020).  
Individuals with vascular risk often show only subtle deficits, yet they are at risk for 
developing vascular dementia in the future if the underlying risk factors remain 
uncontrolled (Ates et al., 2020; Azarpazhooh et al., 2019; Hughes et al., 2020; Ng et al., 
2016; Pal et al., 2018).  Cardiovascular risk factors include hypertension, obesity, 
diabetes, dyslipidemia (i.e., high levels of low-density lipoprotein cholesterol [LDL], low 
levels of high-density lipoprotein cholesterol [HDL], high levels of triglycerides) and 
hyperglycemia (i.e., high fasting blood glucose) (Grundy, 2005; Triposkiadis et al., 
2019).  Vascular risk factors often do not present with symptoms that are easily detected 
or experienced by the individuals (i.e., patients may not feel ‘sick’) (Bennett, 2017), so 
individuals may be unaware that their vitals are abnormal and that their cardiovascular 
health is outside of the normal range.  However, these risk factors have been shown to 
impair cognitive functioning.  Chronic hypertension is a leading cause of age-related 
cognitive impairment in executive function, processing speed, and, less frequently, 





2016; Mehra et al., 2020; Moraes et al., 2019; Ou et al., 2020; Zhou et al., 2019).  
Diabetes mellitus has been associated with impaired attention, processing speed, 
executive function, and verbal memory (Cakir et al., 2020; Karvani et al., 2019; Kim, 
2019; Lyu et al., 2020; Moheet et al., 2015; Sinclair et al., 2020; Valenza et al., 2020; 
Zhao et al., 2020; Zilliox et al., 2016).  Negative associations between obesity and 
executive function have been reported in the literature (Bischof & Park, 2015; Dye et al., 
2017; Favieri et al., 2019; Ganguli et al., 2020; Yang et al., 2018).  Elevated risk factors 
below current threshold for clinical diagnosis have also been associated with poorer 
cognitive performance, highlighting the potential impact of subclinical risk (Kresge et al., 
2018; Sacre et al., 2018; Wendell et al., 2009).  Untreated vascular risk factors can lead to 
more serious conditions such as cardiovascular disease (i.e., conditions of the heart blood 
vessels), cerebrovascular disease (i.e., conditions of the brain blood vessels), and vascular 
dementia (see Pal et al., 2018 for a review).  Given these associations, individuals with 
poor vascular health may be at greater risk for cognitive impairment.   
Vascular risk factors rarely occur in isolation but often present together in a 
clinical constellation.  First described as ‘Syndrome X’ (Reaven, 1988) and ‘Insulin 
Resistance Syndrome’, the name ‘Metabolic Syndrome’ was introduced by the World 
Health Organization in 1998 to describe this specific co-occurrence of vascular risk 
factors (Oda, 2018).  Over the past few decades, the incidence of Metabolic Syndrome 
(MetS) has risen in tandem with rising numbers of its component vascular risk factors 





al., 2015; Hirode & Wong, 2020) of U.S. adults are considered to have MetS, with age 
continually cited as a major risk factor (Lai et al., 2020; Zheng et al., 2020).  The most 
recent data analyzes MetS trends, with more than one third of adults of all socioeconomic 
groups in the U.S. meeting diagnostic criteria (Hirode & Wong, 2020; Moore et al., 
2017).  Given these climbing numbers, MetS has been considered a rising health 
epidemic. 
MetS has been associated with age-related cognitive changes (Assuncao et al., 
2018; Bae et al., 2017; Bezrukov et al., 2018; Lai et al., 2020), accelerated cognitive 
aging (Kulshreshtha et al., 2019; Tsentidou et al., 2019), and an increased risk for 
vascular dementia (Atti et al., 2019; Lee et al., 2020; Moon et al., 2019; Ng et al., 2016; 
Pal et al., 2018).  Component risk factors of MetS (e.g., dyslipidemia) lead to fatty 
buildup in the blood vessels (i.e., atherosclerosis) which, over time, causes the vessels to 
narrow and restricts the flow of oxygen-rich blood (Blumenfeld, 2018; Sudo et al., 2017). 
Atherosclerotic vessel narrowing is especially dangerous to small blood vessels as it may 
lead to occlusion of the vessel with serious consequences such as infarct or hemorrhage 
(Blumenfeld, 2018; Sudo et al., 2017).  Over time, this chronic damage (i.e., small vessel 
disease) results in subcortical lesions, including lacunar infarcts and cerebral 
microbleeds, that interrupt interconnections among different brain regions and cause 
disturbances to complex cognitive functions (Sudo et al., 2017). Many small vessels sit 
within frontal-subcortical circuits, highlighting that cognitive abilities dependent upon the 





functions, may be particularly vulnerable to vascular risk (Pugh & Lipsitz, 2002). The 
literature supports this assertion, linking vascular risk factors with deficits in executive 
functioning (e.g., planning, organizing, multi-tasking) (Moraes et al., 2019; Yang et al., 
2018).  Across the literature, executive dysfunction is the predominant cognitive deficit 
associated with MetS (Alcorn et al., 2019; Falkowski et al., 2014; Lai et al., 2020; Ogawa 
et al., 2020; Reijmer et al., 2011; Rouch et al., 2014; Schuur et al., 2010; Strong et al., 
2020; Viscogliosi et al., 2015; Yates et al., 2012).  MetS has also been linked to deficits 
in memory (Komulainen et al., 2007, Ogawa et al., 2020; Rouch et al., 2014; Strong et 
al., 2020), verbal memory (Bezrukov et al., 2018; Dik et al., 2007), visual working 
memory (Raffaitin et al., 2011), attention (Bezrukov et al., 2018), sustained attention 
(Wooten et al., 2019), fluid intelligence (Dik et al., 2007; Ghisletta et al., 2019), 
information processing speed (Dik et al., 2007; Przybycien-Gaweda et al., 2020), and 
general cognition (Dik et al., 2007; Lai et al., 2020; Przybycien-Gaweda et al., 2020; 
Raffaitin et al., 2011; Viscogliosi et al., 2012).  These cognitive deficits may be linked to 
underlying structural brain abnormalities associated with MetS, including reduced 
cortical thickness in frontal, parietal, and occipital regions (Schwarz et al., 2018), 
decreased gray matter volume in predominantly frontal and temporal areas (Kotkowski et 
al., 2019), microstructural damage to gray and white matter (Sala et al., 2014), as well as 
silent lacunar infarcts, periventricular white matter hyperintensities, and subcortical white 





pathophysiological mechanisms (e.g., metabolic, inflammatory) may contribute to both 
neuroanatomical changes and cognitive decline (Wang et al., 2016).   
MetS can begin as early as middle age with poor cardiovascular health in midlife 
as a significant predictor of later life executive dysfunction (Debette et al., 2011; 
Knopman et al., 2018).  Many individuals with MetS often show only subtle cognitive 
deficits, yet they are at risk for developing vascular dementia in the future, especially if 
the underlying risk factors remain uncontrolled (Ates et al., 2020; Azarpazhooh et al., 
2019; Ng et al., 2016).  Longitudinal studies have demonstrated the negative impact of 
midlife MetS on later life cognitive functioning (Bangen et al., 2019), as well as the 
association of later life MetS with accelerated cognitive and functional decline (i.e., 
inability to perform basic activities of daily living [ADLs; e.g., bathing, dressing] and 
complex instrumental activities of daily living [IADLs; e.g., shopping, managing 
finances]) (Viscogliosi et al., 2017).  Recent studies have demonstrated the link between 
good cardiovascular health during midlife and better outcomes in later life including 
better physical functioning and lower risk for dementia (Sabia et al., 2019; Urtamo et al., 
2020; von Bonsdorff et al., 2019).  Because deficits associated with vascular risk factors 
may progress over time, with subtle cognitive impairment preceding full-blown dementia 
(Farias et al., 2017), early identification of subtle cognitive deficits may help identify 
those at risk for developing vascular dementia in the future and engender lifestyle 
changes (e.g., behavioral modification, medication use) (Reamy et al., 2018) that may 





may be an excellent screening tool for individuals with MetS.  If the dCIB can detect 
early changes to cognition, particularly executive deficits expected in individuals with 








In this research, we administered the dCIB to a community-based sample of 
adults who have not been identified as cognitively impaired but may exhibit subtle 
cognitive deficits associated with poor vascular health.  We addressed four aims that may 
help showcase the clinical utility of the dCIB.  The dCIB is a novel digitized test and this 
research is the first of its kind to examine its utility. 
Aim 1  
Our first aim was to create cutoff scores for the dCIB.  Cutoff scores indicating cognitive 
impairment offer healthcare providers immediate feedback (i.e., score indicating 
performance outside normal limits) that can be used to inform medical recommendations 
(i.e., referral for comprehensive neuropsychological evaluation).  Not only are cutoff 
scores easy and practical to use, they are also highly feasible in a busy clinic setting (i.e., 
primary care) where staff are under considerable time constraints.   
 Hypotheses Because the same scoring criteria is used for both the paper-and- 
pencil CIB and the dCIB, we expected similar cutoff scores between the two tests.  
Grande and colleagues (2011b) determined clinical cutoff scores for the CIB such 
that suspected impairment reflects a score of 6 or below and probable impairment 
reflects a score of 5 or below. 
Aim 2  
Our second aim was to examine correlations between the dCIB and MMSE to determine 





cognitive screener.  Additionally, we calculated the sensitivity and specificity 
probabilities for the dCIB to determine whether it can correctly identify those with 
impairment (i.e., sensitivity) and correctly identify those without impairment (i.e., 
specificity).  We also calculated sensitivity and specificity for the MMSE and compared 
psychometric data between the two screeners.  Because the MMSE has been criticized for 
its low sensitivity and limited ability to detect subtle cognitive deficits, findings from this 
aim may help demonstrate the dCIB as a superior screener if it is better able to flag subtle 
impairment.   
 Hypotheses Consistent with previous literature demonstrating significant  
correlations between clock drawing and existing cognitive screeners, we expected 
significant positive correlations between the dCIB and the MMSE.  Additionally, 
we expected higher sensitivity values for the dCIB compared to the MMSE.  Not 
only has the MMSE been criticized for its low sensitivity, clock drawing tasks 
consistently demonstrate good psychometric properties. 
Aim 3 
Our third aim was to determine the predictive validity of the dCIB on cognitive 
functioning.  Neuropsychological tests were used as a performance reference because, 
although lengthy, they are comprehensive assessments of cognitive domains with high 
sensitivity and specificity.  In the interest of reducing the number of variables in our 
analysis, we created domain-specific composite scores which serve as a single 





performance on these composite scores, this would help establish construct validity 
insofar that the dCIB is measuring what it was designed to measure.  Moreover, if 
associations between the dCIB and neuropsychological outcomes were found, this 
finding would be consistent with other studies using clock drawing tasks and would 
therefore provide face validity that the dCIB is capturing cognitive performance.   
Hypotheses Because clock drawing relies on cognitive abilities that span across 
executive function, memory, and attention domains, we expected that the dCIB 
would predict performance on neuropsychological tests that assess these domains.  
Using domain-specific composite scores, we hypothesize that the dCIB will 
predict performance on Composite Scores of Executive Function, Memory, and 
Attention. 
Aim 4 
Our fourth aim was to determine the efficacy of the dCIB as a cognitive screening 
instrument.  Individuals in our sample were separated into groups (MetS versus non-
MetS) using current diagnostic criteria for MetS (see Methods).  If the dCIB was able to 
correctly differentiate groups based on cognitive performance, this may establish its 
ability to identify subtle cognitive impairment in this population.  Because of the 
executive elements embedded within the test, the dCIB may be especially useful for 
populations and disorders with executive dysfunction.  This highlights a potential 





currently the most widely used cognitive screener despite its omission of items assessing 
executive functioning.   
Hypotheses Executive dysfunction has been shown to be the predominant 
cognitive deficit associated with MetS; therefore, we expected a lower Executive 
Function Composite Score in the MetS group relative to the non-MetS group.  
Although MetS has been linked to deficits in memory and attention, these 
findings are far less robust than the association between MetS and executive 
dysfunction and, therefore, we did not expect significant group differences on 
Composite Scores of Memory or Attention.  Moreover, we expected lower dCIB 
scores in the MetS group relative to the non-MetS group.  With its inclusion of 
executive elements, we expected the dCIB to be sensitive to executive 





CHAPTER TWO – METHODS 
Study Design 
This research was designed to be cross-sectional with data from veterans and 
civilians aged between 45 and 90 years.  Participants were recruited through multiple 
sources including targeted newspaper advertisements, flyers on the VA Boston 
Healthcare System and Harvard Medical School campuses, posters on the MBTA transit 
system, word of mouth, and direct recruitment from clinics within the VA Boston 
Healthcare System (Preventative Cardiology, Geriatric Research, Education, and Clinical 
Center [GRECC], Neuropsychology, Neurology, Optometry, Diabetes).  Preliminary 
inclusionary and exclusionary criteria were determined by phone screen (see Sample for 
details). If determined eligible, participants were scheduled for a future visit and mailed 
details about the study, instructions to prepare, and directions to the lab located at the VA 
Boston Healthcare System campus in Jamaica Plain, Massachusetts.   
Beginning the evening before the scheduled study visit, participants were 
instructed to complete a 10 to 12 hour fast (water allowed) to prepare for the blood draw.  
Upon arrival to the lab, participants reviewed a detailed consent form during which they 
were free to choose whether or not to partake in the research study.  Background and 
health information was collected by study staff in the form of questionnaires and 
interviews.  Questions focused broadly on educational level, work history, history with 
smoking and alcohol consumption, past surgeries, other major accidents or illnesses, 





collected, as certain medications are known to have an effect on brain structure and 
cognitive function. 
Participants completed a blood draw as well as a brief health evaluation (see 
Sample for details).  All measures were collected by a phlebotomist.  Blood samples of 
approximately 26ml were aliquoted and sent for processing to Quest Diagnostics for 
chemistry and cholesterol analysis.   
Our study used a sample of participants collected as part of a larger research 
project designed to examine the impact of vascular risk factors on brain structure and 
function.  Because untreated vascular risk factors have been shown to impair cognitive 
functioning, participants were administered a comprehensive neuropsychological battery 
consisting of paper-and-pencil tests and computerized tasks to assess cognitive status.  In 
the interest of reducing variables, we created composite scores of three general cognitive 
domains: executive function, memory, and attention.  We were interested in these 
particular domains because of their association with vascular risk in the literature (Alcorn 
et al., 2019; Bezrukov et al., 2018; Dik et al., 2007; Falkowski et al., 2014; Komulainen 
et al., 2007; Reijmer et al., 2011; Rouch et al., 2014; Schuur et al., 2010; Viscogliosi et 
al., 2015; Yates et al., 2012).  The presence of vascular risk factors has been repeatedly 
linked to deficits in executive functioning (Gatlin & Insel, 2015; Moraes et al., 2019; 
Yang et al., 2018), and therefore we chose to include measures of executive function as 
part of the neuropsychological assessment.  Associations between vascular risk and 





on memory tests in individuals with vascular risk compared to controls, while other 
studies report little/no association between vascular risk and memory performance (see 
Alcorn et al., 2019 for a review).  Attentional deficits are also inconsistent in the vascular 
literature, with some studies reporting worse attention in individuals with vascular risk 
compared to controls (Wooten et al., 2019) and other studies reporting little/no 
association between vascular risk and attention (see Alcorn et al., 2019 for a review).  
Therefore, we chose to include measures of both memory and attention in our assessment 
in order to determine whether vascular risk impacts these cognitive domains in our 
sample.  
This study was supported by grants from the National Institute of Neurological 
Disorders and Stroke (NINDS) and Consortia for Improving Medicine with Innovation 
and Technology (CIMIT).  Protocol approval was granted by the Institutional Review 
Board (IRB) of the VA Boston Healthcare System. 
Sample 
Inclusionary criteria included English-speaking adults between the ages of 45 and 
90 years with or without symptoms of MetS.  Willingness to complete a 10 to 12 hour 
fast and subsequent blood draw was required for inclusion.  Willingness and ability to 
undergo an MRI scan was also required for inclusion. 
Exclusionary criteria included a history of any of the following medical 
conditions: stroke; heart attack, cardiac arrest, or congestive heart failure; dementia; 





multiple sclerosis; head injury with a loss of consciousness for more than 30 minutes;  
HIV; hepatitis C; severe liver functioning issues (hepatic encephalopathy); emphysema; 
moderate to severe chronic obstructive pulmonary disease; seizure disorder; severe 
anemia; severe hypothyroidism or hyperthyroidism; severe visual or hearing impairment; 
and cancer in which the individual received chemotherapy or radiation treatment within 
the last 12 months.  Individuals with a history of neurosurgery, cardiac surgery, or other 
major surgery were excluded.  Further exclusionary criteria included a history of any of 
the following psychiatric or substance abuse conditions: schizophrenia; psychotic 
disorder; current major depressive disorder; bipolar disorder; severe obsessive-
compulsive disorder; agoraphobia; severe anxiety disorder; drug addiction for cocaine, 
heroin, or any other drugs besides alcohol or marijuana; and hospitalization (greater than 
a week) for severe psychiatric issues.  Participants were also excluded if taking 
medications known to negatively affect performance on cognitive tests or central nervous 
system functioning. 
Participants underwent physiological and metabolic assessment including vital 
sign and body measurements (height in inches, weight in pounds, waist-to-hip ratio), as 
well as a blood draw to collect fasting glucose and a full cholesterol panel with the 
following outcome variables: low density lipoprotein (LDL), high density lipoprotein 
(HDL), triglycerides, total cholesterol, fasting glucose, insulin, and glycated hemoglobin 
(A1C).  For part of our analysis, we characterized our sample into MetS and non-MetS 





Education Program (NCEP) Adult Treatment Panel III: (1) abdominal obesity, defined by 
elevated waist circumference greater than or equal to 40 inches (males) or 36 inches 
(females); (2) dyslipidemia, defined by elevated triglycerides greater than 150 mg/dL or 
(3) reduced HDL less than or equal to 40 mg/dL (males) or 59 mg/dL (females); (4) 
hypertension, defined by elevated blood pressure greater than or equal to 130/85 mmHG; 
and (5) elevated fasting plasma glucose greater than 100 mg/dL (“Executive Summary”, 
2001; Grundy, 2005).  Triglycerides, HDL levels, and blood pressure were counted as 
abnormal if these symptoms were being controlled through medication or other drug 
treatments (“Executive Summary”, 2001; Grundy, 2005).  If three or more NCEP-III 
criteria were met, participants were classified into a MetS group; if fewer than three 
NCEP-III criteria were met, participants were classified in a non-MetS group.  Statistical 
analyses were performed on demographic information (t-tests for age and education; chi 
square tests for gender and ethnicity/race) to determine whether significant differences 
exist between these groups, and any variable determined to be significantly different was 






Neuropsychological testing was administered to provide an assessment of 
executive function, memory, and attention.  Multiple tests within each domain were 
administered to create a more complete understanding of individual cognitive 
functioning. 
Executive functioning has been shown to be the strongest cognitive predictor of 
everyday “real world” functioning (Mansbach & Mace, 2019; McDougall et al., 2019; 
Farias et al., 2009), with recent literature exploring the specific subdomains of executive 
functioning (e.g., inhibition, shifting attention) most involved in functional abilities 
(McAlister & Schmitter-Edgecombe, 2016).  Longitudinal studies have reported that poor 
executive functioning at baseline is a significant predictor of future functional decline in 
community-dwelling older adults (Kraybill et al., 2013) as well as individuals with 
vascular dementia (Jefferson et al., 2006).  Given that many everyday tasks rely on 
underlying executive functions, age-related and/or vascular-related declines in executive 
functioning may lead to functional deficits that could negatively impact functional 
independence (e.g., IADLs; shopping, managing finances).   
Changes in memory are one of the most common cognitive complaints among 
older adults (Howieson et al., 2015; Park et al., 2019), and tests of memory can be used to 
differentiate normal age-related memory changes (e.g., declines in speed of information 
processing, problems remembering names) from abnormal functioning (e.g., dementia) in 





returning veterans and is therefore appropriate to assess in a sample that includes 
veterans. 
Attention is a building block upon which other cognitive abilities rely and, 
therefore, must be included in any assessment to ensure observed deficits are due to 
underperformance in a particular domain (e.g., executive function, memory) and not from 
underlying inattention and distractibility.   
“Typical approaches to the characterization and classification of cognitive 
performance in clinical neuropsychology refer to domains of cognitive performance. 
Within each domain there are typically subdomains, which refer to component ability 
processes within the larger constructs. Individual neuropsychological tests are 
characterized under these subdomains, with these tests measuring one or more discrete 
abilities” (Harvey, 2019, p. 227).  Utilizing this approach, we grouped the following list 
of measures by domain, subdomain, and the individual tests administered to our sample, 







This executive test is intended to measure the spontaneous production of words 
under restricted search conditions (Strauss et al., 2006).  Word generation 
includes tests of both phonemic and category fluency.  Phonemic fluency tasks 
require participants to orally produce as many words as possible that begin with a 
specified letter (i.e., F, A, S) within one minute.  Category fluency tasks require 
participants to orally produce as many words as possible that belong to a 
designated semantic category (i.e., animals) within one minute.  For this study, 
word generation was evaluated with the Letter Fluency + Category Fluency 
conditions of the Delis-Kaplan Executive Function System (D-KEFS) Verbal 
Fluency Test (Delis et al., 2001).  Test performance was based on the total 
number of words generated across F, A, and S (Letter Fluency) and the total 
number of words generated for the Animals category (Category Fluency).  
Performance was compared to published normative data (Delis et al., 2001). 
Shifting Attention 
This executive test is intended to measure attention, cognitive flexibility, and 
processing speed using specific skills of visual scanning and number-letter 
switching (Strauss et al., 2006).  Tests of shifting attention require participants to 
change their focus of attention from one stimulus or stimulus domain to another.  





connecting encircled numbers and letters in alternating and ascending order (1, A, 
2, B, 3, C…) as quickly as possible.  For this study, shifting attention was 
evaluated with the Number-Letter Switching condition of the Delis-Kaplan 
Executive Function System (D-KEFS) Trail Making Test (Delis et al., 2001).  
Test performance was based on time to completion (Number-Letter Switching).  
Performance was compared to published normative data (Delis et al., 2001). 
Color-Word Inhibition 
This executive test is intended to measure cognitive flexibility and inhibition of a 
familiar or dominant response (Strauss et al., 2006).  Tests of color-word 
inhibition require participants to name the color of printed words and inhibit or 
ignore reading the word (the dominant response).  Stimulus words (color names) 
are printed in colored ink.  For this study, color-word inhibition was evaluated 
with the Inhibition condition of the Delis-Kaplan Executive Function System (D-
KEFS) Color Word Interference Test (Delis et al., 2001).  Test performance was 
based on time to completion (Inhibition).  Performance was compared to 
published normative data (Delis et al., 2001). 
Memory 
Word List Learning and Memory 
This memory test is intended to measure verbal learning and memory using 
multiple-trial supra-span list learning tasks (Strauss et al., 2006).  Tests are 





conditions.  For this study, word list learning and memory were evaluated with 
the California Verbal Learning Test II (CVLT-II; Delis, 2000).  Participants were 
read aloud 16 words from a list and asked to recall the words over the course of 
five learning trials.  After a 20 minute delay, participants were again asked to 
spontaneously recall words from the list.  Test performance was based on total 
correct responses from trial learning (Trials 1-5 Free Recall [possible range of 0-
80]) and total correct responses from delayed recall (Long Delay Free Recall 
[possible range of 0-16]).  We chose to exclude Cued Recall conditions on the 
CVLT-II because cueing provides the participant a way to organize words by 
category, thereby removing self-generated organizational strategies.  We also 
chose to exclude Recognition given that this condition facilitates retrieval beyond 
the active, complex search process required in Free Recall conditions.  
Performance was compared to published normative data (Benedict et al., 1998; 
Delis, 2000). 
Story/Narrative Memory 
This memory test is intended to measure verbal learning and memory using a 
story format (Strauss et al., 2006).  This test includes both immediate learning and 
delayed memory.  We chose to include a story memory test as it closely resembles 
everyday memory demands and provides information as to how context and 
meaning contribute to learning and recall (Lezak et al., 2004).  For this study, 





Wechsler Memory Scale IV (WMS-IV; Wechsler, 2009).  Participants were read 
aloud two short stories and asked to immediately retell each story in full detail.  
Repeated presentation of one of the stories was offered for individuals over the 
age of 65 years.  Following a 20 to 30 minute delay, participants were again asked 
to retell the stories in full detail.  Test performance was based on spontaneous 
recollection of story details immediately following story presentation (Immediate 
Recall [possible range of 0-25]) and spontaneous recollection of story details 
following a delay after presentation (Delayed Recall [possible range of 0-25]).  
We chose to exclude the Recognition condition given that it places less demands 
on memory retrieval compared to Free Recall conditions.  Performance was 
compared to published normative data (Wechsler, 2009). 
Nonverbal Learning and Memory 
This memory test is intended to measure visual learning and memory (Strauss et 
al., 2006).  Tests are administered to assess both immediate (learning) and 
delayed (memory) conditions.  Nonverbal memory tests often use abstract 
geometric designs or nonsense figures as an attempt to minimize verbal encoding 
(e.g., ‘this looks like a house’).  For this study, nonverbal learning and memory 
were evaluated with the Brief Visuospatial Memory Test Revised (BVMT-R; 
Benedict, 1997).  Participants were shown a visual display of six figures arranged 
in a 2 x 3 matrix over three consecutive 10 second learning trials and asked to 





delay, participants were asked to draw the figures from memory.  Scoring is based 
on a 2 point scale for both figure accuracy (1 point) and figure placement (1 
point) for each detail of the drawing [range of 0-2 for each figure, 6 figures].  Test 
performance was based on the number of correct figure details recalled 
immediately following the learning trials (Total Recall [possible range of 0-36]) 
and following a delay (Delayed Recall [possible range of 0-12]).  We chose to 
exclude Recognition given that this condition facilitates retrieval beyond the 
active search process required in Free Recall conditions.  Performance was 
compared to published normative data (Benedict, 1997). 
Attention 
Auditory Attention 
This attention test is intended to measure simple attention using auditory stimuli.  
For this study, auditory attention was evaluated using Digit Span Forward on the 
Digit Span subtest of the Wechsler Adult Intelligence Scale IV (WAIS-IV; 
Wechsler, 2008).  Participants listened to a sequence of numbers and repeated the 
numbers out loud in the same order.  Test performance was based on total correct 
responses (Digit Span Forward [possible range of 0-16]).  Performance was 
compared to published normative data (Wechsler, 2008). 
Visual Attention 
This attention test is intended to measure focused attention and processing speed, 





2006).  For this study, visual attention was evaluated using the Number 
Sequencing condition of the Delis-Kaplan Executive Function System (D-KEFS) 
Trail Making Test (Delis et al., 2001).  Participants were asked to draw lines to 
connect numbers randomly arranged on a page into ascending order (1, 2, 3, 4, 
5…) as quickly as possible.  Test performance was based on time to completion 
(Number Sequencing).  Performance was compared to published normative data 
(Delis et al., 2001). 
Comparison Measure 
Digital Clock in the Box (dCIB) 
The Digital Clock in the Box (dCIB) is a digitized version of the CIB that is 
administered on an iPad tablet.  In consultation with Dr. Laura Grande, the dCIB 
was programmed for the purposes of this study by John Stricker, Ph.D., who was 
familiar with the paper version of the CIB.  To administer the dCIB, participants 
were handed an iPad Air (screen size of 9.7 inches) and a stylus pen.  A practice 
trial was administered to familiarize participants with how to use the tablet and 
stylus.  For the practice trial, four dots forming the corners of a 3” square were 
centered on the screen and participants were asked to use the stylus to connect the 
dots.  If needed, the practice trial was repeated up to four times.  If unable to 
complete the practice trial after the fourth attempt, test administration for the 
dCIB was discontinued. Following the practice trial, the dCIB was administered. 





following carefully” (in Times font and 16 font size, bold and italicized) and a list 
of four instructions (in Times font and 20 font size): (1) “In the blue box on the 
next page”, (2) “Draw a picture of a clock”, (3) “Put in all the numbers”, and (4) 
“Set the hands to ten after eleven”.  Once participants read through the 
instructions, they selected the “Next” button, which removed the instructions and 
prompted the response screen.  The response screen showed four boxes 
(approximately 2.25” x 3.5”) with colored outlines (yellow, red, green, blue) each 
in a quadrant, with the blue box positioned in the lower right quadrant.  When a 
response location was selected, the selected box increased in size (approximately 
4” x 5”) while the other boxes became disabled.  Participants then used the stylus 
to complete the task in the selected box.  Scoring for the dCIB is completed using 
an 8 point total scale (1 point each, range of 0-8, with lower scores indicating 
poorer performance), consisting of a 4 point Working Memory Subscore and a 4 
point Planning/Organization Subscore. The Working Memory (WM) Subscore 
focuses on four details specific to the set of written instructions including: (1) 
whether the drawing is completed in the correct (blue) square (credit is given if 
the drawing is in the blue square or if the blue box itself is used as the clock’s 
outline; no credit is awarded if the clock is drawn in multiple boxes or across 
multiple boxes); (2) whether the drawing resembles a clock (any type of clock is 
acceptable [e.g., grandfather clock]); (3) whether the drawing includes all 





[e.g., written in a line] as well as numbers written in Roman numerals; no credit is 
awarded if any number(s) other than 1-12 are present); and (4) whether the correct 
time is indicated (credit is given if time is written [e.g., “ten past eleven”] or if the 
11 and 2 are circled or otherwise highlighted).  The Planning/Organization (P/O) 
Subscore focuses on four organizational and abstract features of the clock 
including: (1) whether the drawing is an appropriate size (credit is given if the 
drawing is small enough to fit in the blue square, does not intersect other squares, 
and is large enough to accommodate numbers 1-12; no credit is awarded if the 
blue box itself is used as the clock’s outline); (2) whether the numbers are in 
correct order (numbers may be written in any format [e.g., in a line]); (3) whether 
the numbers are evenly spaced and drawn within the clock’s outline (credit is 
given if the opposing anchor numbers of 3 & 9 and 12 & 6 are relatively well-
aligned and the other numbers are relatively well placed; no credit is given if 
numbers intersect the perimeter of the clock or if two or more quadrants have 
poor number spacing); and (4) whether the clock hands originate at the center of 
the drawing and are drawn of different lengths (the hour hand must be 80% or less 
the length of the minute hand, and the origin of hands must be drawn within 50% 
of the clock center).  Test performance was based on the dCIB Total Score, which 
is calculated by adding the WM Subscore and the P/O Subscore.  Complete 





Neuropsychological Composite Scores 
As described above, a number of cognitive measures were included to assess the 
domains of interest, and a number of specific scores were utilized to assess these 
behaviors.  To reduce the number of variables in our analysis, composite scores were 
created from the means of standardized scores for the outcome variables of the 
neuropsychological tests administered to our sample.  The use of domain-specific 
cognitive composite scores, which serve as a single representative score for a cognitive 
domain, has grown in popularity as a preferred method in neuropsychological assessment 
data analysis (Jonaitis et al., 2019; Crane et al., 2012; Gibbons et al., 2012).  We used a 
theory-driven approach in which established neuropsychological theories are used to 
combine scores within a particular cognitive domain (Jonaitis et al., 2019; Riordan, 
2017).  The choice of individual tests used to create composite scores closely matches the 
study designs for populations of aging (Halliday et al., 2019; Palta et al., 2018), mild 
cognitive impairment (MCI) (Ganguli et al., 2019), Alzheimer’s Disease (AD) (Bejanin 
et al., 2017; Malek-Ahmadi et al., 2018), and vascular risk (Boss et al., 2017; Lal et al., 
2017).   
Raw test scores were converted into standardized z-scores based on age adjusted 
published norms, and these individual test z-scores were then averaged into z-score 
composites.  We created composite scores for three general cognitive domains: executive 
function, memory, and attention.  The Executive Function Composite Score was created 





The Memory Composite Score was created from tests of (1) word list learning and 
memory, (2) story/narrative memory, and (3) nonverbal learning and memory.  Lastly, 
the Attention Composite Score was created from tests of (1) auditory attention, and (2) 
visual attention. Participants without at least one test from each of these domains were 
excluded from analysis.  A complete list of tests administered to our sample is provided 






CHAPTER THREE – AIMS, HYPOTHESES, & STATISTICAL ANALYSES 
AIM 1: DETERMINE CLINICAL CUTOFF SCORES FOR THE DCIB  
Hypotheses 
• Clinical cutoff scores have been established for the paper-and-pencil CIB (Grande 
et al., 2011b) such that suspected impairment reflects a score of 6 or below and 
probable impairment reflects a score of 5 or below; because the same scoring 
criteria is used for both the dCIB and CIB, we hypothesized similar cutoff scores 
between the dCIB and CIB. 
Statistical Analysis (using IBM SPSS statistical software version 27) 
• To determine optimal cutoff values for the dCIB, we used a receiver operating 
characteristic (ROC) curve to plot the true positive rate (i.e., sensitivity; 
proportion of impaired individuals for which the dCIB correctly identifies as 
impaired) against the false positive rate (i.e., 1 – specificity; proportion of 
unimpaired individuals for which the dCIB incorrectly identifies as impaired) in 
our sample for all possible cutoff scores.  Participants were dichotomized based 
on cognitive impairment.  Based on the typical criteria for cognitive impairment 
among MCI populations (see Petersen & Morris, 2005), evidence of impairment 
in our sample was determined by neuropsychological scores falling more than 1.5 
SD below appropriate norms from at least two tests within any cognitive domain 
(Jak et al., 2009).  If neuropsychological scores fell more than 1.5 SD below 





unimpaired. We ran an ROC curve analysis (test variable = dCIB Total Score; 
state variable = cognitive impairment) which offered a graphical illustration of the 
true positive rate (i.e., sensitivity) and false positive rate (i.e., 1 – specificity) for 
all possible cutoff scores, with each point on the plot corresponding to a cutoff 
score.  For our ROC curve analysis, we reported each cutoff score and its 
corresponding true positive and false positive rates. In the literature, a commonly 
used approach for cutoff selection is based on the Youden index (J), which 
describes the summation of true positive and false positive rates for each score (J 
= sensitivity + [specificity – 1]) (Habibzadeh et al., 2016).  On the graph, the 
Youden index represents the point on the ROC curve with the highest vertical 
distance from the 45° diagonal reference line (this line represents the output of a 
test with no diagnostic value) (Habibzadeh et al., 2016).  In our analysis, the dCIB 
score that corresponded with the maximum Youden index was determined to be 






AIM 2: INVESTIGATE HOW THE DCIB COMPARES TO THE MMSE 
• Correlations between the dCIB and MMSE to determine concurrent validity and 
compare performance between these tests 
• Sensitivity and specificity probabilities to compare psychometric properties 
between the dCIB and MMSE 
Hypotheses 
• Prior research shows significant correlations between clock drawing and existing 
cognitive screeners like the MMSE (Palsetia et al., 2018); therefore, we 
hypothesized significant positive correlations between the dCIB and the MMSE. 
• Because clock drawing tasks consistently demonstrate good psychometric 
properties (Shulman, 2000) and the MMSE has been criticized for its low 
sensitivity (de Roeck et al., 2019; Mitchell, 2009), we hypothesized higher 
sensitivity values for the dCIB compared to the MMSE in the detection of 
cognitive impairment. 
Statistical Analysis (using IBM SPSS statistical software version 27) 
• To compare the dCIB and the MMSE, a bivariate Pearson’s r correlation was 
calculated (variables = dCIB Total Score, MMSE Total Score).  Pearson’s r 
correlational coefficient ranges from 1 (i.e., perfect positive correlation; as one 
variable increases, the other variable increases) to -1 (i.e., perfect negative 
correlation; as one variable increases, the other variable decreases), and 0 





was determined to be statistically significant if the p-value was ≤ 0.05.  For this 
correlation, we reported the Pearson’s r value as well as the p-value. 
• To create sensitivity and specificity probabilities, participants were dichotomized 
based on cognitive impairment criteria described in Aim 1 (i.e., impairment if 
neuropsychological scores fall more than 1.5 SD below appropriate norms from at 
least two tests within any cognitive domain; no impairment if neuropsychological 
scores fall more than 1.5 SD below appropriate norms on 0-1 tests from within 
any domain).  Cutoff scores from Aim 1 were entered into a 2x2 cross-tabulation 
(row = dCIB impairment; column = cognitive impairment) to determine 
sensitivity and specificity for the dCIB.  This same methodology was repeated for 
the MMSE.  MMSE scores were dichotomized using a cutoff score of 25, with 
impairment classified by an MMSE score of ≤ 25 while MMSE scores > 26 were 
classified as unimpaired.  These variables were entered into a 2x2 cross-tabulation 
(row = MMSE impairment; column = cognitive impairment) to determine 
sensitivity and specificity for the MMSE.  For each cross-tabulation in our 





AIM 3: DETERMINE PREDICTIVE VALIDITY OF THE DCIB ON COGNITIVE 
FUNCTIONING 
Hypotheses 
• Clock drawing relies on cognitive abilities that span across executive function, 
memory, and attention domains (Young, 2018; Freedman, 1994); using 
regression modeling, we hypothesized that the dCIB would predict 
performance on tests that assess executive functioning, memory, and attention.  
Using domain-specific composite scores, we hypothesized that the dCIB 
would predict performance on Composite Scores of Executive Function, 
Memory, and Attention. 
Statistical Analysis (using IBM SPSS statistical software version 27) 
• A set of linear regressions were conducted where the dCIB was entered into a 
linear regression model predicting each of the three Composite Scores: (IV = 
dCIB Total Score; DVs = Composite Score [Executive Function Composite 
Score, Memory Composite Score, Attention Composite Score]).  A useful 
property of a linear regression is that it can be used to predict the value of one 
variable (i.e., Composite Score) based on the value of another variable (i.e., 
dCIB score).  Output from a linear regression provides the correlation (R 
value), as well as how much of the total variance in the outcome is explained 
by the predictor (R2 value).  For our predictor, we reported the unstandardized 





B), t-test statistic (t), and p-value (p).  The B coefficient tells us the nature of 
the relationship between the outcome variable (i.e., Composite Score) and the 
predictor variable (i.e., dCIB score), with the ± sign indicating the direction of 
the relationship.  For every 1 unit increase in the predictor variable, the 
outcome variable either increases (+ sign) or decreases (- sign) by the B 
coefficient. In our analysis, a predictor variable was determined to be 






AIM 4: APPLICATION OF THE DCIB IN A SAMPLE STRATIFIED BY 
VASCULAR RISK 
• Neuropsychological differences between MetS and non-MetS groups using 
generated Composite Scores of Executive Function, Memory, and Attention 
• dCIB performance differences between MetS and non-MetS groups 
Hypotheses 
• Executive dysfunction has been shown to be the predominant cognitive deficit 
associated with MetS (Alcorn et al., 2019); therefore, we hypothesized a lower 
Executive Function Composite Score in the MetS group relative to the non-
MetS group.  Although MetS has been linked to deficits in memory and 
attention (Alcorn et al., 2019), these findings are far less robust than the 
association between MetS and executive dysfunction; therefore, we did not 
expect significant group differences on Composite Scores of Memory or 
Attention. 
• With its inclusion of executive elements, we expected the dCIB to be sensitive 
to executive dysfunction in individuals with vascular risk; therefore, we 
hypothesized lower dCIB scores in the MetS group relative to the non-MetS 
group. 
 
Statistical Analysis (using IBM SPSS statistical software version 27) 
• Statistical analyses were performed on demographic information (t-tests for 





whether significant differences exist between MetS and non-MetS groups.  In 
the case that a demographic variable is determined to be significantly different 
between groups, an ANCOVA is used in place of an ANOVA for the 
remainder of the statistical analyses to accommodate for the covariate(s). 
• Multivariate ANOVA was used to determine whether MetS and non-MetS 
groups differ on neuropsychological performance using generated Composite 
Scores of Executive Function, Memory, and Attention (IV = group [MetS, 
non-MetS]; DVs = Executive Function Composite Score, Memory Composite 
Score, Attention Composite Score).  In order to better understand what 
individual tests were driving our findings, we broke down the significant 
Composite Scores to their individual test z scores and compared performance 
across groups.  Significance was determined by a p-value of ≤ 0.05.  For each 
of the three Composite Scores, we reported the F-value and the p-value 
generated by the ANOVA. 
• Multivariate ANOVA was used to determine whether MetS and non-MetS 
groups differ on dCIB performance (IV = group [MetS, non-MetS]; DVs = 
dCIB Total Score, WM Subscore, P/O Subscore).  Significance was 
determined by a p-value of ≤ 0.05.  For the dCIB and its subscores, we 





CHAPTER FOUR – RESULTS 
Detailed characteristics for our sample (N=63) are listed in Table 2.  In this community-
based sample of adults, the average age was 62.49 ± 9.16 years [range of 46 to 80].   
Participants were mostly college-educated with a mean of 16.46 ± 2.76 years of 
education [range of 10 to 20], male (55.6%), and reflected the demographic composition 
of the greater Boston area (U.S. Census Bureau, 2019) [self-identified White (69.9%); 
self-identified non-White (28.6%)].  Eleven participants (17.5% of total sample) met 
criteria for cognitive impairment.  Evidence of cognitive impairment was determined by 
neuropsychological scores falling more than 1.5 SD below appropriate norms from at 
least two tests within any cognitive domain.   
 
Age, in years M (SD) 62.49 (9.16) 
Education, in years M (SD) 16.46 (2.76) 
Gender   
     Male n (% total) 35 (55.6%) 
     Female n (% total) 28 (44.4%) 
Ethnicity   
     White n (% total) 44 (69.9%) 
     Non-White n (% total) 18 (28.6%) 
           Black or African American n 11 
           Hispanic or Latino n 2 
           Asian n 5 
     Missing/ Prefer not to respond n (% total) 1 (1.5%) 
Cognitive Impairment   
     Impaired n (% total) 11 (17.5%) 
     Unimpaired n (% total) 52 (82.5%) 
 






Table 3 provides descriptive statistics across all neuropsychological measures 
administered to our sample.  Table 4 shows a frequency table of scores for dCIB Total 
Score and WM and P/O Subscores. 
 
 M (SD) Range 
   
Cognitive Screeners   
     MMSE 28.19 (2.06) 22–30 
     dCIB Total Score 6.32 (2.32) 0–8 
          WM Subscore 3.29 (1.13) 0–4 
          P/O Subscore 3.03 (1.29) 0–4 
   
Executive Function   
     D-KEFS VF Letter Fluency 45.57 (14.70) 14–85 
     D-KEFS VF Category Fluency 43.92 (11.59) 22–80 
     D-KEFS TMT Number-Letter Switching + 101.41 (42.41) 43–250 
     D-KEFS CWI Inhibition + 62.95 (17.50) 32–107 
   
Memory   
     CVLT-II Trials 1-5 Free Recall 48.95 (12.10) 26–75 
     CVLT-II Long Delay Free Recall 10.43 (3.53) 2–16 
     WMS-IV LM Immediate Recall 15.90 (4.67) 3–25 
     WMS-IV LM Delayed Recall 14.35 (4.60) 4–23 
      BVMT-R Total Recall 19.89 (7.37) 4–34 
      BVMT-R Delayed Recall 8.29 (3.09) 0–12 
   
Attention   
     Digit Span Forward 10.57 (2.39) 6–16 
     D-KEFS TMT Number Sequencing + 39.92 (15.54) 20–111 
   
Composite Scores   
     Executive Function Composite Score 0.00 (0.74) -2.09 – 2.13 
     Memory Composite Score 0.00 (0.82) -1.78 – 1.56 
     Attention Composite Score 0.00 (0.71) -1.99 – 0.71 
   
+ Denotes a timed test, such that a lower value indicates better performance 





 0 1 2 3 4 5 6 7 8 
dCIB Total Score 5 0 0 2 2 7 10 7 30 
     WM Subscore 5 0 3 19 36 -- -- -- -- 
     P/O Subscore 5 4 9 11 34 -- -- -- -- 
 








AIM 1: DETERMINE CLINICAL CUTOFF SCORES FOR THE DCIB 
A receiver operating characteristic (ROC) curve was run to determine optimal cutoff 
scores for the dCIB (test variable = dCIB Total Score; state variable = cognitive 
impairment).  Cognitive impairment was determined by neuropsychological scores falling 
more than 1.5 SD below appropriate norms from at least two tests within any cognitive 
domain (Jak et al., 2009). Our analysis generated various cutoff scores and their 
corresponding true positive and false positive rates [see Table 5].  Figure 1 illustrates the 
graphical ROC curve produced by plotting the true positive rate (i.e., sensitivity) and 
false positive rate (i.e., 1 – specificity) for each possible cutoff score, with each point on 
the plot corresponding to a cutoff score.  The area under the ROC curve (AUC) was a 
value of 0.767.  Our results reveal that the cutoff value corresponding with the maximum 
Youden index (J = 0.463) was a score of 5.5.  Because the dCIB was scored using whole 
numbers (i.e., 0, 1, 2) we posit that a score ≤ 6 indicates suspected impairment and a 







Figure 1. Graph of ROC Curve for All Possible dCIB Cutoff Scores 
  
Maximum 


















-1.00 0.000 0.000 -- 
1.50 0.364 0.019 0.345 
3.50 0.364 0.058 0.306 
4.50 0.364 0.096 0.268 
5.50* 0.636 0.173 0.463 
6.50 0.727 0.346 0.381 
7.50 0.818 0.462 0.356 
9.00 1.000 1.000 -- 
* Cutoff score with the maximum Youden Index 
 






AIM 2: INVESTIGATE HOW THE DCIB COMPARES TO THE MMSE 
 
Correlations between the dCIB and MMSE 
All participants completed the dCIB and MMSE measures.  A bivariate Pearson’s r 
correlation was calculated to assess the relationship between the dCIB and MMSE 
(variables = dCIB Total Score, MMSE Total Score) [see Table 6].  Results revealed 
significant positive correlations between the MMSE and dCIB, such that a lower score on 
the dCIB correlates with a lower score on the MMSE, r(61) = 0.437, p = 0.000.  Figure 2 
illustrates the positive correlation between the dCIB and MMSE using a scatterplot. 
 
 MMSE Total Score 
   
 Pearson’s r Sig. (2 tailed) 
   
dCIB Total Score** 0.437 0.000 
* Outcome is significant at the 0.05 level 
** Outcome is significant at the 0.01 level 
 













Sensitivity and specificity probabilities for the dCIB and MMSE 
dCIB cutoff scores from Aim 1 were entered into a 2x2 cross-tabulation (row = dCIB 
impairment; column = cognitive impairment) to determine sensitivity and specificity for 
the dCIB [see Table 7].  Results differed based on a dCIB cutoff score of 6 (sensitivity 
72.7%; specificity 65.4%) or a dCIB cutoff score of 5 (sensitivity 63.6%; specificity 
82.7%) [see Table 8].  MMSE scores (impairment classified by an MMSE score of ≤ 25) 
were also were entered into a 2x2 cross-tabulation (row = MMSE impairment; column = 
cognitive impairment) [see Table 7].  Results revealed a sensitivity of 45.5% and a 
specificity of 94.2% on the MMSE [see Table 8].  These results indicate better sensitivity 







  n % n % 
Total  11 100% 52 100% 
dCIB  


































Table 7. Cross-tabulations between Cognitive Impairment and Impairment on the 





 Sensitivity Specificity 
   
dCIB suspected impairment (≤ 6) 72.7% 65.4% 
dCIB probable impairment (≤ 5) 63.6% 82.7% 
MMSE 45.5% 94.2% 
 





AIM 3: DETERMINE PREDICTIVE VALIDITY OF THE DCIB ON COGNITIVE 
FUNCTIONING 
Executive Function Composite Score 
 
A linear regression was calculated to determine the predictive validity of the dCIB on 
executive functioning (IV = dCIB Total Score; DV = Executive Function Composite 
Score) [see Table 9].  The B coefficient suggests that a higher dCIB score is associated 
with a higher Executive Function Composite Score.  Our model moderately predicted 
performance on standardized measures of executive functioning (R = 0.302), with 9.1% 
of variance in the outcome explained by the predictor. Results from this regression reveal 
that dCIB score (t = 2.477, p = 0.016) is a significant predictor of the Executive Function 
Composite Score, thereby providing preliminary support for associations between the 
dCIB and executive functioning.  Figure 3 visually illustrates the regression of the 
Executive Function Composite Score using a scatterplot. 
 
 B SE B t p 95% CI for B 
     Lower Upper 
       
dCIB Total Score** 0.096 0.039 2.477 0.016 0.019 0.174 
* Outcome is significant at the 0.05 level 
** Outcome is significant at the 0.01 level 
 













Memory Composite Score 
A linear regression was calculated to determine the predictive validity of the dCIB on 
memory (IV = dCIB Total Score; DV = Memory Composite Score) [see Table 10].  The 
B coefficient suggests that a higher dCIB score is associated with a higher Memory 
Composite Score.  Our model moderately predicted performance on standardized 
measures of memory (R = 0.383), with 14.7% of variance in the outcome explained by 
the predictor. Results from this regression reveal that dCIB score (t = 3.242, p = 0.002) is 
a significant predictor of the Memory Composite Score, thereby providing preliminary 
support for associations between the dCIB and memory.  Figure 4 visually illustrates the 
regression of the Memory Composite Score using a scatterplot.  
 
 B SE B t p 95% CI for B 
     Lower Upper 
       
dCIB Total Score** 0.136 0.042 3.242 0.002 0.052 0.220 
* Outcome is significant at the 0.05 level 
** Outcome is significant at the 0.01 level 
 












Attention Composite Score 
A linear regression was calculated to determine the predictive validity of the dCIB on 
attention (IV = dCIB Total Score; DV = Attention Composite Score) [see Table 11].  The 
B coefficient suggests that a higher dCIB score is associated with a higher Attention 
Composite Score.  Our model moderately predicted performance on standardized 
measures of attention (R = 0.367), with 13.5% of variance in the outcome explained by 
the predictor. Results from this regression reveal that dCIB score (t = 3.082; p = 0.003) is 
a significant predictor of the Attention Composite Score, thereby providing preliminary 
support for associations between the dCIB and attention.  Figure 5 visually illustrates the 
regression of the Attention Composite Score using a scatterplot. 
 
 B SE B t p 95% CI for B 
     Lower Upper 
       
dCIB Total Score** 0.113 0.037 3.082 0.003 0.040 0.186 
* Outcome is significant at the 0.05 level 
** Outcome is significant at the 0.01 level 
 












AIM 4: APPLICATION OF THE DCIB IN A SAMPLE STRATIFIED BY 
VASCULAR RISK 
The sample used in the present study consisted of 63 participants characterized into MetS 
(n=21) or non-MetS (n=42) groups using NCEP-III criteria.  In order to determine 
whether significant differences in demographic variables exist between our groups, t-tests 
were performed on age and education and chi square tests were performed on gender and 
ethnicity/race [see Table 12].  No significant group differences were found on education 
between the MetS group (M = 16.29 years, SD = 2.952) and the non-MetS group (M = 
16.55 years, SD = 2.698); t(61) = 0.352, p = 0.726.  There were also no significant group 
differences on gender between the MetS group (male [n=13, 61.9%]; female [n=8, 
38.1%]) and the non-MetS group [male [n=22, 52.4%]; female [n=20, 47.6%]); x2(1, N = 
63) = 0.514, p = 0.473.  Additionally, there were no significant group differences found 
on ethnicity/race between the MetS group (White [n=16, 76.2%]; non-White [n=5, 
23.8%]) and the non-MetS group (White [n=27, 64.2%]; non-White [n=13, 31.0%]); x2(4, 
N = 63) = 2.127, p = 0.712.  However, there was a significant difference in age between 
the MetS group (M = 67.10 years, SD = 7.81) and the non-MetS group (M = 60.19 years, 
SD = 8.98); t(61) = -2.997, p = 0.004.  To account for this difference, the following 










    
Age, in years* M (SD) 67.10 (7.81) 60.19 (8.98) 
Education, in years M (SD) 16.29 (2.95) 16.55 (2.69) 
Gender    
     Male n (% total) 13 (61.9%) 22 (52.4%) 
     Female n (% total) 8 (38.1%) 20 (47.6%) 
Ethnicity    
     White n (% total) 16 (76.2%) 28 (66.6%) 
     Non-White n (% total) 5 (23.8%) 13 (31.0%) 
          Black or African American n 4 7 
          Hispanic or Latino n 0 2 
          Asian n 1 4 
     Missing/ Prefer not to respond n (% total) 0 (0%) 1 (2.4%) 
Cognitive Impairment    
     Impaired n (% total) 4 (19.1%) 7 (16.6%) 
     Unimpaired n (% total) 17 (80.9%) 35 (83.3%) 
* Outcome is significant at the 0.05 level 
** Outcome is significant at the 0.01 level 
 





 MetS (n=21) Non-MetS (n=42) 
     
 M (SD) Range M (SD) Range 
     
Cognitive Screeners     
     MMSE 27.76 (1.61) 25–30 28.40 (2.23) 22–30 
     dCIB Total Score 5.33 (2.75) 0–8 6.81 (1.93) 0–8 
          WM Subscore 2.76 (1.34) 0–4 3.55 (0.92) 0–4 
          P/O Subscore 2.57 (1.54) 0–4 3.26 (1.11) 0–4 
     
Executive Function     
     D-KEFS VF Letter Fluency 41.71 (14.32) 14–71 47.50 (14.67) 27–85 
     D-KEFS VF Category Fluency 40.67 (8.95) 25–57 45.55 (12.49) 22–80 
     D-KEFS TMT Number-Letter   
     Switching + 
110.29 (50.32) 54–250 96.98 (37.73) 43–206 
     D-KEFS CWI Inhibition + 66.90 (15.44) 45–107 60.98 (18.29) 32–106 
     
Memory     
     CVLT-II Trials 1-5 Free Recall 45.25 (11.75) 27–63 50.76 (12.00) 26–75 
     CVLT-II Long Delay Free Recall 9.50 (3.15) 4–15 10.88 (3.66) 2–16 
     WMS-IV LM Immediate Recall 15.52 (5.08) 3–22 16.10 (4.49) 4–25 
     WMS-IV LM Delayed Recall 13.67 (4.78) 6–20 14.69 (4.53) 4–23 
     BVMT-R Total Recall 17.00 (6.87) 4–29 21.33 (7.26) 7–34 
     BVMT-R Delayed Recall 7.10 (3.09) 2–12 8.88 (2.94) 0–12 
     
Attention     
    Digit Span Forward 9.95 (1.99) 7–13 10.88 (2.53) 6–16 
    D-KEFS TMT Number Sequencing + 44.43 (17.76) 27–111 37.67 (13.99) 20–94 
     
Composite Scores     
 
Executive Function Composite Score -0.2445 (0.66) -2.09 –0.71 
0.1223 (0.75) -1.45 – 
2.13 
 
Memory Composite Score -0.2638 (0.68) -1.69 – 0.93 
0.1371 (0.86) -1.78 – 
1.56 
 
Attention Composite Score -0.2746 (0.66) -1.99 – 0.92 
0.1373 (0.71) -1.23 – 
1.71 
+ Denotes a timed test, such that a lower value indicates better performance 







Neuropsychological differences between MetS and non-MetS groups 
 
Two participants did not complete the CVLT-II due to time limitations. All 
participants completed the D-KEFS Verbal Fluency, D-KEFS Trail Making Test, D-
KEFS Color-Word Inhibition, WMS-IV Logical Memory, BVMT-R, Digit Span, and 
dCIB measures.  Because there was a significant difference in age between the MetS and 
non-MetS groups, age adjusted ANCOVA analyses were used in place of ANOVA tests 
for the following statistical analyses.   
A set of univariate ANCOVA tests, controlling for age, was completed to 
compare performance between MetS and non-MetS groups on cognitive functioning (IV 
= group [MetS, non-MetS]; DV = Composite Score [Executive Function Composite 
Score, Memory Composite Score, Attention Composite Score]; covariate = age) [see 
Table 14].  We found significant group differences on the Executive Function Composite 
Score, such that the MetS group [M = -0.2445, SD = 0.66] performed worse on executive 
functioning measures relative to the non-MetS group [M = 0.1223, SD = 0.75]; F(1,62) = 
4.122, p = 0.047.  Performance differences between our groups approached significance 
on the Memory Composite Score (MetS group [M = -0.2638, SD = 0.68]; non-MetS 
group [M = 0.1371, SD = 0.86]; F(1,62) = 3.551, p = 0.065).  We also found significant 
group differences on the Attention Composite Score, such that the MetS group [M = -
0.2746, SD = 0.66] performed worse on attention measures relative to the non-MetS 





To better understand which tests were driving our findings, we broke down the 
Composite Scores to their individual test z scores and compared performance across 
groups. Univariate ANCOVA tests, adjusting for age, were completed to compare 
performance between MetS and non-MetS groups on individual tests used to generate our 
Composite Scores (IV = group [MetS, non-MetS]; DV = neuropsychological measure [D-
KEFS Verbal Fluency, D-KEFS Trail Making Test, D-KEFS Color-Word Inhibition, 
CVLT-II, WMS-IV Logical Memory, BVMT-R, Digit Span]; covariate = age) [see Table 
14].  We found significant group differences, such that the MetS group performed worse 
than the non-MetS group, on the following measures: D-KEFS Verbal Fluency Letter 
Fluency (MetS group [M = -0.2624, SD = 0.97]; non-MetS group [M = 0.1312, SD = 
0.99]; F(1,62) = 4.118, p = 0.047); BVMT-R Total Recall (MetS group [M = -0.3921, SD 
= 0.93]; non-MetS group [M = 0.1960; SD = 0.98]; F(1,62) = 4.315, p = 0.042); BVMT-
R Delayed Recall [MetS group [M = -0.3856, SD = 1.00]; non-MetS group [M = 0.1928, 
SD = 0.95]; F(1,62) = 4.689, p = 0.034), and Digit Span Forward (MetS group [M = -
0.2593, SD = 0.83]; non-MetS group [M = 0.1296, SD = 1.06]; F(1,62) = 4.282; p = 










     
 M (SD) M (SD) F Sig. 
     
Executive Function Composite Score* -0.2445 (0.66) 0.1223 (0.75) 4.122 0.047 
     D-KEFS VF Letter Fluency* -0.2624 (0.97) 0.1312 (0.99) 4.118 0.047 
     D-KEFS VF Category Fluency -0.2806 (0.77) 0.1403 (1.08) 2.043 0.158 
     D-KEFS TMT Number-Letter Switch -0.2092 (1.19) 0.1046 (0.89) 2.206 0.143 
     D-KEFS CWI Inhibition -0.2258 (0.88) 0.1129 (1.05) 1.046 0.311 
     
Memory Composite Score -0.2638 (0.68) 0.1371 (0.86) 3.551 0.065 
     CVLT-II Trials 1-5 Free Recall -0.3057 (0.97) 0.1491 (0.99) 2.792 0.100 
     CVLT-II Long Delay Free Recall -0.2622 (0.89) 0.1279 (1.03) 1.916 0.172 
     WMS-IV LM Immediate Recall -0.0816 (1.09) 0.0408 (0.96) 0.797 0.376 
     WMS-IV LM Delayed Recall -0.1482 (1.04) 0.0741 (0.98) 1.214 0.275 
     BVMT-R Total Recall* -0.3921 (0.93) 0.1960 (0.98) 4.315 0.042 
     BVMT-R Delayed Recall* -0.3856 (1.00) 0.1928 (0.95) 4.689 0.034 
     
Attention Composite Score* -0.2746 (0.66) 0.1373 (0.71) 4.284 0.043 
     Digit Span Forward* -0.2593 (0.83) 0.1296 (1.06) 4.282 0.043 
     D-KEFS TMT Number Sequencing -0.2900 (1.14) 0.1450 (0.90) 0.816 0.370 
     
* Outcome is significant at the 0.05 level 
** Outcome is significant at the 0.01 level 
 





dCIB performance differences between MetS and non-MetS groups 
A set of univariate ANCOVA tests, controlling for age, was completed to compare 
performance between MetS and non-MetS groups on the dCIB (IV = group [MetS, non-
MetS]; DVs = dCIB Total Score, WM Subscore, P/O Subscore; covariate = age) [see 
Table 15].  We found a significant group difference on dCIB Total Score between MetS 
(M = 5.33, SD = 2.75) and non-MetS groups (M = 6.81, SD = 1.93); F(1,61) = 8.975, p = 
0.004, such that the MetS group performed worse on the dCIB relative to the non-MetS 
group.  Figure 6 illustrates mean group differences on dCIB Total Score.  Results also 
revealed a significant difference between MetS and non-MetS groups on both the WM 
and P/O Subscores of the dCIB.  We found significant group differences on the WM 
Subscore such that the MetS group had lower overall WM Subscores relative to the non-
MetS group (MetS group [M = 2.76, SD = 1.34]; non-MetS group [M = 3.55, SD = 0.92]; 
F(1,61) = 11.547, p = 0.001), as well as significant group differences on the P/O 
Subscore such that the MetS group had lower overall P/O Subscores relative to the non-
MetS group (MetS group [M = 2.57, SD = 1.54]; non-MetS group [M = 3.26, SD = 1.11]; 
F(1,61) = 5.787, p = 0.019).  Figure 7 illustrates mean group differences on the WM and 











     
 M (SD) M (SD) F Sig. 
     
dCIB Total Score** 5.33 (2.75) 6.81 (1.93) 8.975 0.004 
     WM Subscore** 2.76 (1.34) 3.55 (0.92) 11.547 0.001 
     P/O Subscore* 2.57 (1.54) 3.26 (1.11) 5.787 0.019 
* Outcome is significant at the 0.05 level 
** Outcome is significant at the 0.01 level 






Figure 6. Bar Graph of Mean Group Performance Differences on dCIB Total Score. 
Line Indicates Standard Error. 
 
 
Figure 7. Bar Graph of Mean Group Performance Differences on dCIB WM 





















































A   B  
C   D  
 
Figure 8.  Sample dCIB drawings.  dCIB A represents a score of 3 because the drawing 
is an appropriate size, resembles a clock, and is drawn in the correct box.  Points were 
deducted for number inclusion, number order, number spacing, time, and hand length and 
origin.  dCIB B represents a score of 5 because the drawing is an appropriate size, 
resembles a clock, is drawn in the correct box, and shows the correct time with hands of 
appropriate length and origin.  Points were not given for number inclusion, number order, 
and number spacing.  dCIB C represents a score of 6, with 2 points deducted because the 
drawing shows the incorrect time and is drawn in the incorrect box.  dCIB D represents a 
score of 8 because the drawing is an appropriate size, resembles a clock, is drawn in the 
correct box, includes all numbers in the correct order with appropriate spacing, and 









In recent years, clock drawing has become a popular cognitive screening test 
because of its brief and simple administration, acceptability among patients, low cost, 
good psychometric properties, sensitivity to subtle cognitive impairment, and evidence of 
significant correlations with other established and validated cognitive tests (Hazan et al., 
2018; Ismail et al., 2010; Nyborn et al., 2013; Rabin et al., 2005; Shulman, 2000; 
Shulman et al., 2006).  In this research, we introduce the digital Clock in the Box [dCIB], 
a novel digitized clock drawing task with strengthened executive elements.  Over the 
course of four aims, we illustrate its clinical utility as a cognitive screener. 
For our first aim, we created cutoff scores for the dCIB.  Cognitive screening 
instruments are designed to optimize time and efficiency in healthcare settings (i.e., 
primary care) by providing quick feedback regarding cognitive status.  Cutoff scores that 
help classify patients as “impaired” (i.e., score indicating performance outside normal 
limits) or “unimpaired” (i.e., score indicating performance within normal limits) are both 
practical and feasible in a busy clinic setting where staff are under considerable time 
constraints. Although these scores are not in and of themselves diagnostic, they may 
indicate the likelihood of cognitive impairment so that patients may be referred to a 
specialist (e.g., clinical neuropsychologist) who can provide more extensive, 
comprehensive, and diagnostic neuropsychological assessment.  Our results revealed that 





2016) and was therefore determined to be the optimal cutoff score, with a dCIB score ≤ 6 
indicating suspected impairment and a dCIB score ≤ 5 indicating probable impairment.  
These values are consistent with cutoff scores created for the paper-and-pencil CIB 
(Grande et al., 2011b).  Despite differing formats for administration (digital versus paper-
and-pencil), we expected similar cutoff scores between the dCIB and CIB given that both 
tests utilize the same scoring criteria [see Appendix B].  Similar cutoffs between the two 
tests provide a type of concurrent validity – although, ideally, subsequent studies should 
directly compare performance on the dCIB and CIB to provide stronger evidentiary 
support of concurrent validity. 
For our second aim, we compared the dCIB to the MMSE.  Because the MMSE is 
the most commonly used cognitive screener for dementia (de Roeck et al., 2019; Tsoi et 
al., 2015), it is often used for comparison against other measures.  The dCIB and the 
MMSE were found to be significantly correlated, which supports our hypothesis and is 
consistent with existing literature reporting significant correlations between clock 
drawing and the MMSE (Palsetia et al., 2018).  By demonstrating that our novel test 
correlates well with a previously validated test (i.e., MMSE), we provide evidence of 
concurrent validity.  A significant relationship between scores from the dCIB and scores 
from the MMSE suggests that the two screeners measure the same construct (i.e., 
cognitive functioning) and differentiate individuals in the same way (i.e., impaired or 





(Carnero-Pardo, 2014), associations between the MMSE and the dCIB suggest that the 
dCIB might also be successfully used to screen for cognitive impairment. 
We also compared psychometric data between the dCIB and the MMSE.  We 
calculated the sensitivity and specificity probabilities for both the dCIB and the MMSE to 
determine how well each test could correctly identify those with impairment (i.e., 
sensitivity) and those without impairment (i.e., specificity).  Results revealed better 
sensitivity and poorer specificity on the dCIB compared to the MMSE.  We expected 
higher sensitivity values for the dCIB not only because clock drawing has good 
psychometric properties (Shulman, 2000) but because the MMSE has been criticized for 
its low sensitivity (de Roeck et al., 2019; Mitchell, 2009).  Better sensitivity on the dCIB 
means that it may identify a greater number of true positive results (cognitively impaired 
individuals correctly identified as impaired) compared to the MMSE, which suggests a 
better ability to screen for cognitive impairment.  However, poorer specificity suggests 
that the dCIB may also identify a greater number of false positive results (cognitively 
unimpaired individuals incorrectly identified as impaired) for which there are potential 
costs to both the patient (e.g., emotional and psychosocial consequences; unnecessary 
follow-up neuropsychological evaluation and/or treatment) and the healthcare system 
(e.g., economic costs; misallocated time and energy of healthcare providers).  
Intraindividual variability is characteristic of healthy adults and, therefore, abnormal 
performance on some proportion of neuropsychological tests in a battery is 





2003).  Reduced specificity for the dCIB may be explained by patient factors that affect 
test performance.  Greater age and lower education have been reported to influence 
performance on neuropsychological tests (Hebben & Milberg, 2009; Lam et al., 2013; 
Shanhu et al., 2019; Bento-Torres et al., 2017; Tripathi et al., 2014); therefore, the broad 
range of ages [46 and 80 years] and levels of education [10 to 20 years] in our sample 
might contribute to low specificity.  Numerous non-neurological factors may also 
negatively impact performance on the dCIB including medication effects, sleep 
deprivation, or fatigue from lengthy neuropsychological testing (Hebben & Milberg, 
2009; Adhikari et al., 2020; Roy et al., 2020; Ma et al., 2020; Kusztor et al., 2019; Aasvik 
et al., 2018; Strober & DeLuca, 2013).  Other possible sources for false positive errors 
(i.e., psychiatric status, depression) were excluded for in the original design of the study; 
however, it is possible that participants were not formally diagnosed with a condition and 
therefore did not indicate presence of an exclusionary criteria.  Although the goal is to 
maximize both sensitivity and specificity, the two are often inversely related so increased 
sensitivity usually comes at the expense of reduced specificity.  The creation of two 
cutoff scores for the dCIB offers an advantage because, if higher specificity is desired, a 
cutoff value of ≤ 5 (sensitivity of 63.6%; specificity of 82.7%) may be used over a cutoff 
value ≤ 6 (sensitivity of 72.7%; specificity of 65.4%).  The optimal balance between 
sensitivity and specificity may depend on the purpose for which the test is used (Hebben 
& Milberg, 2009).  Ideally, screening tests should be highly sensitive in order to detect as 





tests (i.e., comprehensive neuropsychological evaluation) should be highly specific to 
ensure that individuals flagged for impairment are truly impaired (Hebben & Milberg, 
2009).   
Sensitivity and specificity values for both suspected impairment (dCIB score ≤ 6) 
and probable impairment (dCIB score ≤ 5) are generally consistent with literature on 
psychometric values for clock drawing (Smedslund et al., 2015). Values for the MMSE 
are also consistent with previous literature reporting low sensitivity (Mitchell, 2009).  
The MMSE is predominantly used on populations with significant cognitive dysfunction 
(i.e., dementia), which does not describe our sample (i.e., adults with no self-reported 
history of cognitive impairment). Therefore, a possible explanation for low MMSE 
sensitivity in our study is based on the characteristics of our sample.  It is likely that any 
presence of cognitive impairment in our sample is not significant enough to be captured 
by the MMSE.  Furthermore, the MMSE includes fewer items associated with executive 
functioning which may make it unsuitable as a screener for subtle executive deficits 
expected in individuals with vascular risk.  The dCIB, on the other hand, includes 
executive elements designed to increase working memory demands with the goal of 
increasing task sensitivity.  Of the 11 participants in our sample who were identified as 
cognitively impaired from neuropsychological assessment, over half (6 individuals; 
54.5%) were not detected by the MMSE; however, the dCIB (using criteria for probable 
impairment; dCIB score ≤ 5) captured 4 of the 6 individuals who were missed by the 





Executive Function Composite Scores (3 participants with scores greater than 1.5 SD 
below the mean), which went undetected by the MMSE.  This illustrates how the 
executive elements embedded within the dCIB increases overall sensitivity to cognitive 
impairment and offers an advantage over the MMSE, which is currently the most 
commonly used cognitive screener despite its poor sensitivity and limited items assessing 
executive functioning.  
For our third aim, we examined the predictive validity of the dCIB on cognitive 
functioning.  Clock drawing relies on cognitive abilities that span across domains of 
executive function (i.e., developing an organized multi-step plan of action; detecting and 
correcting errors); memory (i.e., retrieving a mental representation of a clock); and 
attention (i.e., concentrating to complete the task) (Young, 2018; Freedman, 1994; 
Amodeo et al., 2015).  Neuropsychological tests assessing these domains are used as a 
performance reference because they are comprehensive assessments of cognitive domains 
and have high sensitivity and specificity, as well as good diagnostic accuracy and 
predictive value.  We created Composite Scores of Executive Function, Memory, and 
Attention from the outcome variables of the neuropsychological tests administered to our 
sample and used these domain-specific composite scores for our analyses.  The dCIB 
significantly predicted performance on all three composite scores, suggesting that dCIB 
score may be a significant predictor of overall executive functioning, memory, and 
attention. This finding is consistent with literature associating clock drawing with these 





beyond the domains of executive function, memory, and attention and therefore 
performance on the dCIB may serve as a broader representative score for general 
cognitive functioning.   
For our fourth aim, we explored whether the dCIB can detect the presence of 
subtle cognitive deficits among individuals with vascular risk.  Evidence that the dCIB 
can detect early changes to cognition, particularly subtle executive deficits associated 
with poor vascular health, may help establish its utility as a cognitive screener.  We 
separated our sample into groups (MetS versus non-MetS) using current diagnostic 
criteria for MetS (i.e., presence of three or more cardiovascular risk factors; see Methods 
for details).  Interestingly, 21 of 63 participants (33.3% of our sample) met criteria for 
MetS which reflects current estimates of MetS levels in the U.S. adult population (1 in 
every 3 adults) (Hirode & Wong, 2020; Moore et al., 2017).  The MetS group scored 
lower on the Executive Function Composite Score compared to the non-MetS group.  We 
expected a lower Executive Function Composite Score in the MetS group given that 
executive dysfunction has been shown to be the predominant cognitive deficit associated 
with MetS (Alcorn et al., 2019).  Poor executive functioning observed in our MetS group 
is consistent with existing literature linking vascular risk factors with deficits in executive 
functioning (Moraes et al., 2019; Yang et al., 2018).  Uncontrolled or poorly controlled 
component risk factors of MetS lead to atherosclerotic vessel narrowing which may cause 
a variety of vascular events (e.g., small vessel disease, stroke) (Blumenfeld, 2018; 





may result in neuroanatomical changes (i.e., lacunar infarcts, cerebral microbleeds) (Sudo 
et al., 2017; Pugh & Lipsitz, 2002).  These neuroanatomical changes have been shown to 
impact a series of parallel pathways that interconnect various regions of the frontal lobe 
to subcortical structures, leading to deficits in cognitive domains dependent upon the 
integrity of these frontal-subcortical circuits including frontally mediated executive 
functions (Sudo et al., 2017; Pugh & Lipsitz, 2002).   
We also found significant group differences on the Attention Composite Score, 
with lower scores in the MetS group compared to the non-MetS group.  Furthermore, the 
MetS group scored lower on the Memory Composite Score relative to the non-MetS 
group, but the difference failed to reach significance.  Both findings do not reflect the 
general literature on the cognitive effects of MetS.  Associations between vascular risk 
and memory are inconsistent, with some studies reporting poorer performance on 
memory tests in individuals with vascular risk compared to controls and other studies 
reporting little/no association between vascular risk and memory performance (see 
Alcorn et al., 2019 for a review).  Attentional deficits are also inconsistent in the vascular 
literature, with some studies reporting worse attention in individuals with vascular risk 
compared to controls (Wooten et al., 2019) and other studies reporting little/no 
association between vascular risk and attention (see Alcorn et al., 2019 for a review).  To 
better understand what might be driving our results, we broke down the Memory and 
Attention Composite Scores to their individual test components and compared 





Although the overall Memory Composite Score (comprising of outcome variables 
from both verbal [i.e., CVLT-II, WMS-IV] and non-verbal tests [i.e., BVMT-R]) was not 
significant, our results revealed significant group differences on non-verbal memory.  
Recent literature has suggested that visual memory may be especially sensitive to 
emergent cognitive decline (De Anna et al., 2014; Didic et al., 2013; Oltra-Cucarella et 
al., 2018; Okonkwo et al., 2014).  For example, Ye and colleagues (2015) found that, 
among a group of MCI patients with verbal deficits and a group of MCI patients with 
visual deficits, the latter group was at greater risk for progression to dementia.  More 
recently, Wasserman and colleagues (2019) found within-group differences among MCI 
patients, such that individuals with dysexecutive MCI performed worse on the BVMT-R 
(total and delayed free recall) compared to individuals with amnestic MCI.  As noted by 
the authors, a possible reason to explain this finding is that visual memory tasks recruit a 
wide set of cognitive domains, including memory (i.e., encoding figures and their 
locations), attention (i.e., visual scanning), executive abilities (i.e., mental planning), and 
motor skills (i.e., drawing a response) and that “the diversity of neurocognitive skills 
necessary in these visual episodic memory tests is far greater than verbal episodic 
memory tests where patients are most often asked to encode and subsequently remember 
a list of words” (Wasserman et al., 2019, p. 3).  Therefore, it is possible that executive 
deficits, like those we see in the MetS group, negatively impact performance on visual 
memory tests to a greater extent than verbal memory tests.  Based on this literature, it is 





emergent decline.  Longitudinal studies support the assertion that poor visual memory 
may be predictive of future decline.  Several studies have reported that changes in visual 
memory may precede a formal diagnosis of dementia by several years (Kawas et al., 
2003; Zonderman et al., 1995).  Summers & Saunders (2012) found that MCI patients 
with baseline deficits on a visual memory task progressed to dementia after 20 months.  
In a recent study examining temporal changes of visual memory in patients diagnosed 
with MCI, Campos-Magdaleno and colleagues (2020) found that low baseline scores 
predicted changes in cognitive status at 18-month follow up, suggesting that “this [visual 
memory] decline may be a cognitive indicator of the progression in the continuum 
ranging from the stage characterized by the presence of cognitive complaints without 
objective cognitive impairment to dementia, through the different levels of severity of 
MCI” (p. 9).  
Significant group differences were also found on Digit Span Forward.  Digit Span 
Forward assesses components of working memory (i.e., the ability to temporarily store 
and manipulate information).  In the literature, a widely accepted model of working 
memory (Baddeley & Hitch, 1974) consists of three components: a verbal storage system 
called the phonological loop, a visual storage system called the visuospatial sketchpad, 
and a central executive.  Digit Span Forward involves momentary storage and rehearsal 
of serial verbal information and is therefore considered a measure of attention span and 
phonological loop capacity.  According to Baddeley and Hitch’s framework (Baddeley & 





eventually exhaust phonological loop capacity and additional processing resources would 
be recruited from the central executive – thus, Digit Span Forward may be influenced by 
both phonological loop and central executive functioning.  It is possible that, when 
completing Digit Span Forward, participants in our study began to rely more heavily on 
executive functions as the digit strings became longer and the task became more 
challenging; therefore, poor performance on Digit Span Forward in the MetS group may 
actually reflect impaired executive functioning.  This theory is supported by studies 
suggesting that the central executive component of working memory is recruited for both 
forward and backward span tasks (Hester et al., 2004; Gregoire & Van der Linden, 1997; 
Miyake et al., 2001).  Although Digit Span Forward is traditionally considered a measure 
of simple attention, Digit Span Backward (i.e., participants listen to a sequence of 
numbers and repeat the numbers out loud in the reverse order) is thought to increase 
executive demands by requiring the simultaneous storage and manipulation of serial 
verbal information.  In a community sample of normally aging adults, Hester and 
colleagues (2004) reported no evidence of a differential rate of decline between forward 
and backward digit span, suggesting that the central executive may contribute to both 
tasks and that age-related declines in executive functioning may impact both tasks 
equivalently.  McCabe and colleagues (2010) used a factor analysis approach to examine 
the relationship between working memory and executive function and found that the two 
constructs were strongly correlated and shared a large proportion of common variance.  





executive function may share a common underlying executive-attention component 
(McCabe et al., 2010). The concept of an executive-attention component to working 
memory was first proposed by Kane and Engle (2002) to describe the active maintenance 
of information in the presence of mental and environmental distractors.  The authors 
posited that the ability to prevent a loss of attentional focus in the presence of 
interference (i.e., inhibitory control) is a critical executive element of working memory 
and the primary mechanism linking the two constructs.  
Given this literature, compromised executive functioning in the MetS group may 
be driving performance on BVMT-R and Digit Span Forward.  If this is true, MetS may 
not be associated with deficits in memory and attention.  Future studies should utilize a 
more extensive assessment battery, including memory and attention tests less reliant on 
executive abilities, to better clarify preserved and compromised areas of functioning 
among individuals with MetS. 
In addition to comparing performance on neuropsychological measures, we also 
compared group performance on the dCIB.  We found that the dCIB successfully 
differentiated MetS and non-MetS groups, with lower dCIB scores in the MetS group 
relative to the non-MetS group.  This finding illustrates the sensitivity of the dCIB in 
detecting subtle cognitive deficits among individuals with vascular risk.  We also found 
significant group differences on WM and P/O Subscores of the dCIB, with worse 
performance in the MetS group relative to the non-MetS group.  On the dCIB, working 





instructions provided before the start of the task, while planning/organization (P/O) 
demands are increased by requiring participants to draw in a predetermined location on 
the response screen (i.e., blue box).  These modifications were designed to increase 
overall task sensitivity and, as a result, improve the detection of cognitive impairment 
beyond traditional clock drawing.  By increasing sensitivity to executive dysfunction, the 
dCIB may be especially useful for populations and disorders with impaired executive 
functioning. 
Altogether, we believe these four aims provide preliminary evidentiary support 
for the clinical utility of the dCIB.  Creating cutoff values for the dCIB that immediately 
classify patients as “impaired” or “unimpaired” facilitates score interpretation for primary 
care physicians and other clinic staff with limited exposure to cognitive assessment.  Not 
only are cutoff scores easy and practical to use, they optimize time and efficiency in 
primary care where the average clinic visit is often less than 20 minutes (Linzer et al., 
2015).  In addition to discussing its potential application in healthcare settings, clinical 
utility for the dCIB was also evaluated by determining test validity.  First, we compared 
how the dCIB performs alongside a commonly used cognitive screener.  We found 
significant correlations between the dCIB and the well-validated MMSE, which 
establishes concurrent validity.  Second, we used neuropsychological tests as a 
performance reference against the dCIB because, although lengthy, they are 
comprehensive assessments of cognitive domains with high sensitivity and specificity.  





construct validity insofar that the dCIB is measuring what it was designed to measure.  
Furthermore, associations between the dCIB and neuropsychological outcomes are 
consistent with other studies using clock drawing tasks and therefore provide face 
validity that the dCIB is capturing cognitive performance.  Lastly, we demonstrated the 
efficacy of the dCIB as a cognitive screening instrument in a community-based sample of 
adults who have not been identified as cognitively impaired.  The dCIB successfully 
detected the presence of subtle cognitive impairment in our sample, particularly subtle 
executive deficits likely associated with poor vascular health, thereby substantiating its 






Study Considerations and Future Directions 
At the heart of preventative medicine, primary care provides patients with routine 
screenings to monitor overall health status; unfortunately, screenings do not typically 
include an evaluation of cognitive status.  It is worthwhile to note that, among our sample 
of adults who had not been identified as cognitively impaired, 11 of 63 participants 
(17.5%) demonstrated compromised performance on neuropsychological testing – 
thereby reinforcing the need for better cognitive screening.  Of the 11 participants who 
were identified as cognitively impaired from neuropsychological assessment, the dCIB 
flagged 8 with suspected impairment (72.7%; dCIB score ≤ 6).  In this study, we explored 
the utility of a novel digitized screener that is brief, simple, and can be used for routine 
cognitive screening in healthcare settings.  
There are several strengths to this research.  (1) Using a diverse sample that is 
representative of the demographic composition of the greater Boston area (U.S. Census 
Bureau, 2019) improves the external validity and generalizability of our findings. (2) 
Comparing the dCIB to other cognitive screeners (MMSE) and neuropsychological tests 
increases face validity that the dCIB is accurately capturing cognitive status. (3) Because 
the dCIB was able to predict cognitive performance, this helps establish construct validity 
insofar that the dCIB is measuring what it was designed to measure. (4) Despite the surge 
of technological devices in the digital era, it is possible that some individuals may not be 
comfortable or may not know how to use an iPad tablet.  Therefore, a practice trial was 





and stylus.  This was included to ensure that a low score on the dCIB was due to poor 
performance and not due to unfamiliarity with the technology. (5) As a digitized measure, 
the dCIB can gather supplementary data (i.e., time to completion, self-corrections, order 
of clock details) with a level of precision and standardization that is difficult or otherwise 
impossible to achieve with traditional paper-and-pencil neuropsychological assessment. 
Evaluating these empirically derived qualitative features (as opposed to unempirical 
qualitative observation) encompasses the spirit of the Boston Process Approach 
(Ashendorf et al., 2013) and has the potential to help elucidate and differentiate patient 
populations.  As the first study utilizing the dCIB, we chose to exclude qualitative data in 
our analysis and instead focus on overall performance; however, future studies may 
choose to analyze qualitative details and use their findings to help refine the dCIB and 
further expand its clinical utility.  
This research also has important limitations. (1) Although our sample is diverse 
and reflects the local demographics, it is also small (N=63) and therefore may not be 
representative of the larger population. However, even with a small sample, we were able 
to see significant effects within our analyses and thus we expect that future studies with 
larger samples would continue to hold similar associations.  (2) Using current diagnostic 
criteria for MetS (“Executive Summary”, 2001; Grundy, 2005), individuals in our sample 
were separated into groups that were of unequal sizes.  The variability of scores observed 
in the smaller MetS group (n=21; M=5.33; SD=2.75), compared to the non-MetS group 





Our neuropsychological battery did not include the paper-and-pencil CIB, and therefore 
we could not directly compare performance between the dCIB and CIB.  Subsequent 
studies will need to administer both the dCIB and CIB to provide evidentiary support of 
concurrent validity.  (4) Like all cognitive screening instruments, the dCIB may be 
challenged by floor and ceiling effects.  A floor effect (i.e., participant scores cluster 
towards the lowest possible value; dCIB score of 0) is likely minimized by our sample of 
adults with no history of cognitive impairment.  However, there is evidence of a ceiling 
effect (i.e., participant scores cluster towards the highest possible value; dCIB score of 8) 
in our study – 30 of 63 participants received a maximum score of 8 – which can be 
explained by the fact that our sample was generally cognitively intact.  Future studies 
should include participants with more cognitive impairment so as to improve 
understanding of the cognitive effects associated with low dCIB scores.  (5) Because the 
dCIB is digitally administered and does not require direct examiner observation, 
clinically useful information may be missed during testing such as important behavioral 
indicators of emotion (i.e., displays of frustration), motivation, and mental status.  Other 
factors potentially impacting test performance (i.e., premorbid reading level, medication 
effects, psychiatric status) may also not be considered.  (6) The dCIB may be unsuitable 
for those with visual or physical handicaps. Drawing a clock may be challenging or 
impossible for individuals who have compromised fine motor movement. Individuals 
with color blindness may struggle to perceive the colored outlines of the four boxes 





may be to change the parameters from color to texture, such that the boxes are outlined 
by single line, double line, dashed line, etc.  (7) Our study did not include longitudinal 
data on cognitive performance. Although we do not know how practice effects might 
disrupt retesting, future studies on dCIB reliability are needed to determine whether 
participants who are flagged for cognitive impairment by the dCIB remain impaired or 
continue to decline over time. Longitudinal assessments will also help determine how 
dCIB performance is affected by cognitive changes associated with normal aging.   
Perhaps the most valuable next step is to create a normative database for the 
dCIB.  Normative data is used to determine how an individual’s performance compares to 
others of the same age and education; therefore, to meaningfully interpret an individual’s 
dCIB score, we must have norms against which we can compare.  Although tempting to 
borrow norms from the paper-and-pencil CIB, it is important to note that programming a 
test for digital administration (i.e., dCIB) creates a new and different test (Bauer et al., 
2012).  “It cannot be assumed that the normative data obtained for an examiner-
administered test apply equally to a computerized version of the same test, due to 
changes in the method used to conduct the administration and variations in computer 
familiarity according to patient demographics” (Bauer et al., 2012, p. 368).  Therefore, 
norms specific to the dCIB must be created.  Future studies will need to create dCIB 
norms for healthy controls and, to further clinical utility, dCIB norms should also be 
created for different clinical populations to show the range and patterns of performance 





Another important next step is to develop software for the iPad that can 
automatically score the dCIB and compare performance to normative data in real time.  
This feature would offer healthcare providers immediate feedback that can be used to 
inform on-the-spot medical recommendations, thereby furthering the clinical utility of the 
dCIB.  
Conclusion 
In this research, we introduced the digital Clock in the Box [dCIB], a novel 
digitized clock drawing task designed to screen for cognitive impairment.  The dCIB is 
quickly and easily administered on an iPad tablet which makes it an ideal option for 
routine cognitive screening in busy primary care settings.  Associations between the 
dCIB and established cognitive screening and standardized neuropsychological measures 
provide support for the validity of the dCIB.  In a sample stratified by vascular risk, the 
dCIB successfully detected subtle deficits associated with poor vascular health and 
differentiated groups based on cognitive impairment, thereby demonstrating its utility and 
success as a screening instrument.  For these reasons, the dCIB shows promise as an 
effective cognitive screener, though additional studies are needed to further expand its 





















Figure 9.  Sample CIB.  During administration of the CIB, participants were given a 
sheet of paper with a set of four instructions: (1) In the blue box on the next page, (2) 
Draw a picture of a clock, (3) Put in all the numbers, and (4) Set the hands to 10 after 11. 
The instructions were taken away and participants were free to draw on the response 
sheet that shows four colored boxes (yellow, red, green, blue) each in a quadrant.  For the 
dCIB, the presentation remains the same, but is administered on an iPad tablet.  Instead of 
switching to a separate paper response sheet, participants swiped to the next screen.   
Note: Reprinted from Clock in the Box by Grande et al., 2011a.  Retrieved from 
http://www.heartbrain.com/cib/clockinstructions.htm   
• In the blue box on the next page 
• Draw a picture of a clock 
• Put in all the numbers 












Drawing is completed in the correct (blue) square 
• Only in the blue square 
• If drawn in multiple boxes (e.g. clock drawn in both blue & yellow boxes), no 
credit is given 
• If drawn across multiple boxes (e.g. large clock covers more than one box), no 
credit is given 





Drawing resembles a clock 





Drawing includes all numbers 
• 1-12 in any order is given credit 
• Numbers any location (e.g. written in a line) is given credit 
• Roman numerals are given credit 





Correct time is indicated in any manner 
• Credit is given if time is written (e.g. “ten past eleven”) 
• Credit is given if the 11 and 2 are circled (or otherwise highlighted) 
• If the participant did not receive credit for the Numbers feature above due to the 












Drawing of clock is appropriate size 
• Small enough to fit in the blue square 
• Should not intersect other squares 
• Large enough to accommodate numbers 1-12 





Numbers are in correct order 





Numbers are evenly spaced and drawn within clock’s outline 
• If clock is scored as appropriate size, no credit is given if numbers intersect 
perimeter of clock 
• Opposing anchor numbers of 3 & 9 and 12 & 6 should be relatively well-
aligned 
• If anchor numbers are well-aligned, the remaining numbers should be relatively 
well placed. If two or more quadrants have poor spacing, no credit is given. 
 
 
Hand Length & Origin 
 
Hands should originate at center of clock and hands should be of different length  
• Hour hand must be 80% or less the length of the minute hand 
• Origin of hands must be within 50% of center 
 
 
WM Subscore + P/O Subscore = dCIB Total Score 
 
Table 16. Detailed Scoring Criteria for the CIB 
 












• Digital Clock in the Box (dCIB) 
 
• Mini-Mental State Exam 2 (MMSE-2) 
 
Executive Function 
• Delis-Kaplan Executive Function System (D-KEFS) – Trail Making Test 
• Delis-Kaplan Executive Function System (D-KEFS) – Verbal Fluency 
• Delis-Kaplan Executive Function System (D-FEKS) – Color Word Interference 
Memory 
• California Verbal Learning Test II (CVLT-II) 
• Wechsler Memory Scale IV (WMS-IV) – Logical Memory 
• Brief Visuospatial Memory Test Revised (BVMT-R) 
Attention 
• Wechsler Adult Intelligence Scale IV (WAIS-IV) – Digit Span  
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